Finesse Ultra Probe Instructions for Use Rev 6 June 2011

Instructions for Use

64 Pages

File Type: PDF

File Size: 1.35 MB

File Name: BARD - Finesse Ultra Probe Instructions for Use Rev 6 June 2011 - 2011-06.pdf

Preview

Page 1

Instructions for Use

A. Device Description The FINESSE® Ultra Breast Biopsy System is composed of a driver and a probe and allows for obtaining and storing multiple samples with a single probe insertion. The components of the system are designed to operate safely when used together for diagnostic sampling of tissue during a biopsy procedure. The driver is a self-contained, handheld, reusable electro-mechanical vacuum-assisted biopsy device that utilizes a rechargeable lithium-ion battery and comes complete with AC power accessories and carrying case. The biopsy probe is composed of a hollow outer cutting cannula, an inner needle with a notched sample chamber, and an integrated coaxial cannula. The outer cannula and integrated coaxial cannula have sharpened cutting edges and the inner needle has a sharpened trocar tip. The driver utilizes DC operated motors to create a vacuum while simultaneously moving the outer cannula backward to expose the sample chamber to draw tissue in. The outer cannula is released and moves forward over the sample chamber to cut the tissue. The tissue sample is transported via the sample chamber to the sample container. The sample chamber is returned to the original position and is available to acquire another sample. The integrated coaxial cannula may be detached after the biopsy and remain in the breast to retain a track to the biopsy site when placing a tissue marker. NOTE: The integrated coaxial cannula must remain attached while acquiring tissue samples. A B C D

Catalog Number

Description

Gauge

F14105US

Ultrasound Biopsy Probe

14G

105mm

17mm

7mm

20mm

F10105US

Ultrasound Biopsy Probe

10G

105mm

21mm

9mm

20mm

B. Indications for Use The FINESSE® Ultra Breast Biopsy System is indicated to obtain tissue samples from the breast or axillary lymph nodes for diagnostic analysis of breast abnormalities. The instrument is intended to provide breast tissue for histologic examination with partial or complete removal of the imaged abnormality. The extent of histologic abnormality cannot be reliably determined from its mammographic appearance. Therefore, the extent of removal of the imaged evidence of an abnormality does not predict the extent of removal of a histologic abnormality e.g., malignancy. When the sampled abnormality is not histologically benign, it is essential that the tissue margins be examined for completeness of removal using standard surgical procedures.

C. Contraindications 1. The FINESSE® Ultra Breast Biopsy System is for diagnostic use only, NOT for therapeutic use. 2. The FINESSE® Ultra Breast Biopsy System is contraindicated for those patients where, in the physician’s judgment, there is an increased risk of complications associated with percutaneous removal of tissue samples.

D. Warnings 1. Patients who may have a bleeding disorder or who are receiving anticoagulant therapy may be at increased risk of complications. 2. As with any biopsy instrument, there is a potential for infection. 3. Do not reuse FINESSE® Ultra Biopsy Probes. Reusing the probe bears the risk of cross-patient contamination as biopsy probes – particularly those with long and small lumina, joints, and/or crevices between FRPSRQHQWV±DUHGLI¿FXOWRULPSRVVLEOHWRFOHDQRQFHERGÀXLGV or tissues with potential pyrogenic or microbial contamination have had contact with the probe for an indeterminable period of time. The residue of biological material can promote the contamination of the probe with pyrogens or microorganisms which may lead to infectious complications. 4. Do not resterilize FINESSE® Ultra Biopsy Probes. After resterilization, the sterility of the probe is not guaranteed because of an indeterminable degree of potential pyrogenic or microbial contamination which may lead to infectious complications. Cleaning, reprocessing and/or resterilizing the probe increases the probability that it will malfunction due to potential DGYHUVHHIIHFWVRQFRPSRQHQWVWKDWDUHLQÀXHQFHGEWKHUPDODQGRU mechanical changes. 5. The FINESSE® Ultra Biopsy Probe must only be used with the FINESSE® Ultra Biopsy Driver. 6. All breast biopsies should be performed under imaging guidance WRFRQ¿UPWKHSUREHSRVLWLRQUHODWLYHWRWKHWDUJHWUHJLRQWREH sampled and to help mitigate the occurrence of a false negative biopsy. The FINESSE® Ultra Biopsy Probe is intended for use with ultrasound imaging only.

E. Precautions 1. Do not use the FINESSE® Ultra Biopsy Probe without the integrated coaxial cannula. The integrated coaxial cannula may be removed after the biopsy to retain a track to the biopsy site when placing a tissue marker. 2. The FINESSE® Ultra Breast Biopsy System should only be used by a physician trained in its indicated use, limitations, and possible complications of percutaneous needle techniques.

ENGLISH

Caution: Federal (USA) law restricts this device to sale by or on the order of a physician. Refer to the FINESSE® Ultra Biopsy Driver Instructions for Use for additional important information. Single-use only.

1. Potential complications are those associated with any percutaneous removal/ biopsy technique for tissue collection. Potential complications are limited to the region surrounding the biopsy site and include hematoma, hemorrhage, infection, a non-healing wound, pain and tissue adherence to the biopsy probe while removing it from the breast. 2. As per routine biopsy procedures, it may be necessary to cut tissue adhering to the biopsy probe while removing it from the breast.

G. Equipment Required The following equipment is required for a biopsy procedure: $SSURSULDWHLPDJLQJPRGDOLWDQGDFFHVVRULHV FINESSE® Ultra Biopsy Driver FINESSE® Ultra Biopsy Probe 6XUJLFDOJORYHVDQGGUDSHV /RFDODQHVWKHWLF 6FDOSHO 2WKHUHTXLSPHQWDVQHFHVVDU

H. Directions for Use Loading the Probe into the Driver 1. Ensure that the driver has been fully charged. The driver should be charged overnight after daily use. 2. Remove the probe from the package using aseptic technique by grasping the probe from below. Ensure that the probe remains sterile. 3. Insert the probe into the driver (Figure 1). 4. Remove the retaining pin (Figure 2). 5. Slide the probe carriage back ensuring the tab securely locks into place (Figure 3). Figure 2 Figure 1 Figure 3

NOTE: The driver does not contain an on-off switch. The driver automatically recognizes the probe type, senses when the probe has been properly inserted and performs an initialization to synchronize the driver and probe. The driver sounds three beeps and the “PRIME/PIERCE” and “SAMPLE” indicator lights display green indicating the probe is properly inserted. During the initialization the motor is audible. 6. After initialization is complete, remove the protective sleeve from the probe. NOTE: Refer to the FINESSE® Ultra Biopsy Driver Instructions for Use for important information on the operation of the driver.

Performing a Biopsy 1. Prepare the biopsy site using appropriate aseptic techniques and adequate local anesthesia. Appropriate precautions should be followed for any percutaneous procedure (personal protective gear such as gloves and glasses/shields, etc. should be worn). 2. Make a small incision or puncture the skin with a scalpel. 3. Using ultrasound guidance, insert the probe through the incision and position the tip to the appropriate depth: ,IWKHOHVLRQLVJRLQJWREH Figure 4 pierced: Position the tip of the probe proximal to the edge of the lesion. Prime/Pierce Sample ,IWKHOHVLRQLVQRWJRLQJ Button Button to be pierced: Position the sampling chamber to the center of the target region. PRIME/ SAMPLE (The center of the sampling PIERCE chamber is approximately 17mm from the tip of the probe.) 4. If piercing is desired, prior to inserting the probe into the breast press the “PRIME/PIERCE” button to retract the probe 20-22mm. After inserting the probe press the “PRIME/PIERCE” button to advance the probe 20-22mm LQWRWKHUHJLRQRILQWHUHVWSULRUWRWDNLQJWKH¿UVWWLVVXHVDPSOH )LJXUH 127(,PDJHJXLGDQFHVKRXOGEHXVHGWRFRQ¿UPSUREHSRVLWLRQUHODWLYH to the target region to be sampled. NOTE: During the initial positioning of the probe, it is recommended to advance the probe into the tissue using the “PRIME/PIERCE” option. During subsequent samplings, the physician may wish to forego this step. NOTE: The probe may be primed for piercing while inside the patient if additional piercing shots are desired to access dense tissue or lesions. 5. Begin tissue sampling by pressing the “SAMPLE” button. The sampling process proceeds automatically: A vacuum is created, the outer cannula of the probe is automatically retracted, tissue is drawn by vacuum into the sampling chamber and the outer cannula is released cutting the tissue. The tissue sample is then transported to the sample container. During this process the “SAMPLE” indicator light continuously illuminates orange and the motor will be audible. The sample container illuminates to aid in visualizing the tissue sample. After the tissue sample is deposited into the sample container the system resets to acquire another sample if desired. NOTE: Do not press on the sample container or remove the sample container while acquiring tissue samples. 6. To acquire multiple samples, repeat Step 5 above. NOTE: Collecting multiple tissue samples may help minimize the risk of a false negative biopsy. 20mm

ENGLISH

F. Potential Complications

/ PRIME E PIERC

20mm

SAMP LE

8. Remove the tissue samples from the sample container by twisting the lid counter clockwise. If additional samples are required, ensure the sample container lid is in place before acquiring additional samples. NOTE: The sample container may be removed completely from the probe by pulling up on the lid and may be removed before or after the probe is removed from the driver. If the probe is loaded into the driver and the sample container is removed from the probe, the “PRIME/PIERCE” and ³6$03/(´LQGLFDWRUOLJKWVZLOOÀDVKRUDQJH$IWHUWKHVDPSOHFRQWDLQHU is reinserted into the probe, the “PRIME/PIERCE” and “SAMPLE” indicator lights will continuously illuminate green. 9. Remove the probe from the driver by pressing down on the locking tab, pushing the carriage completely forward and pulling the probe straight from the driver. (Figure 6). Figure 6 Locking Tab

NOTE: Once a probe has been removed from the driver following a procedure, the probe cannot be re-inserted. If additional tissue samples are required, insert a new probe into the driver. NOTE: Driver will initiate mechanical reset following probe removal. Do not insert a new probe prior to completion of this reset. 10. Refer to the FINESSE® Ultra Biopsy Driver Instructions for Use for important information on cleaning and charging the driver. NOTE: The probe, coaxial cannula and sample container are for single use only. After use, these products may be a potential biohazard. Handle and dispose of in accordance with accepted medical practice and applicable local, state and federal laws and regulations.

I. How Supplied The FINESSE® Ultra Biopsy Probes are supplied sterile for single patient use only.

J. Warranty %DUG3HULSKHUDO9DVFXODUZDUUDQWVWRWKH¿UVWSXUFKDVHURIWKLVSURGXFWWKDWWKLV product will be free from defects in materials and workmanship for a period of RQHHDUIURPWKHGDWHRI¿UVWSXUFKDVHDQGOLDELOLWXQGHUWKLVOLPLWHGSURGXFW warranty will be limited to repair or replacement of the defective product, in Bard Peripheral Vascular’s sole discretion or refunding your net price paid. Wear and tear from normal use or defects resulting from misuse of this product are not covered by this limited warranty. TO THE EXTENT ALLOWABLE BY APPLICABLE LAW, THIS LIMITED PRODUCT WARRANTY IS IN LIEU OF ALL OTHER WARRANTIES, WHETHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT WILL BARD PERIPHERAL VASCULAR BE LIABLE TO YOU FOR ANY INDIRECT, INCIDENTAL OR CONSEQUENTIAL DAMAGES RESULTING FROM YOUR HANDLING OR USE OF THIS PRODUCT. Some states/countries do not allow an exclusion of implied warranties, incidental or consequential damages. You may be entitled to additional remedies under the laws of your state/country. An issue or revision date and a revision number for these instructions are included for the user’s information on the last page of this booklet. In the event 36 months have elapsed between this date and product use, the user should contact Bard Peripheral Vascular, Inc. to see if additional product information is available. Assembled in Poland

ENGLISH

$IWHUREWDLQLQJWKH¿QDOWLVVXHVDPSOHUHPRYHWKHSUREHIURPWKHEUHDVWDQG care for the incision site as appropriate. NOTE: Prior to removing the probe from the breast, the integrated coaxial cannula may be detached and remain in the breast to retain a track to the biopsy site while placing a tissue marker (Figure 5). Figure 5

ǼȁȁǾȃǿȀǹ

ȅįȘȖȓİȢȤȡȒıȘȢ

īȚĮʌİȡĮȚĲȑȡȦıȘȝĮȞĲȚțȑȢʌȜȘȡȠĳȠȡȓİȢĮȞĮĲȡȑȟĲİıĲȚȢȠįȘȖȓİȢȤȡȒıȘȢĲȠȣ ȠįȘȖȠȪȕȚȠȥȓĮȢFINESSE® Ultra. īȚĮȝȓĮȝȩȞȠȤȡȒıȘ

$ ȆİȡȚȖȡĮĳȒıȣıțİȣȒȢ ȉȠıȪıĲȘȝĮȕȚȠȥȓĮȢȝĮıĲȠȪFINESSE® 8OWUDĮʌȠĲİȜİȓĲĮȚĮʌȩȑȞĮȞȠįȘȖȩțĮȚȑȞĮȞțĮșİĲȒȡĮțĮȚ İʌȚĲȡȑʌİȚĲȘȜȒȥȘțĮȚĲȘȞĮʌȠșȒțİȣıȘʌȠȜȜȫȞįİȚȖȝȐĲȦȞȝİȝȓĮȝȩȞȠİȚıĮȖȦȖȒțĮșİĲȒȡĮ ȉĮİȟĮȡĲȒȝĮĲĮĲȠȣıȣıĲȒȝĮĲȠȢİȓȞĮȚıȤİįȚĮıȝȑȞĮȖȚĮȞĮȜİȚĲȠȣȡȖȠȪȞȝİĮıĳȐȜİȚĮȩĲĮȞ ȤȡȘıȚȝȠʌȠȚȠȪȞĲĮȚıİıȣȞįȣĮıȝȩıĲȘįȚĮȖȞȦıĲȚțȒįİȚȖȝĮĲȠȜȘȥȓĮȚıĲȠȪțĮĲȐĲȘįȚĮįȚțĮıȓĮ ȕȚȠȥȓĮȢȅȠįȘȖȩȢİȓȞĮȚȝȚĮĮȣĲȩȞȠȝȘĳȠȡȘĲȒİʌĮȞĮȤȡȘıȚȝȠʌȠȚȒıȚȝȘȘȜİțĲȡȠȝȘȤĮȞȚțȒ ıȣıțİȣȒȕȚȠȥȓĮȢȝİȣʌȠȕȠȒșȘıȘțİȞȠȪȘȠʌȠȓĮȤȡȘıȚȝȠʌȠȚİȓİʌĮȞĮĳȠȡĲȚȗȩȝİȞȘ ȝʌĮĲĮȡȓĮȚȩȞĲȦȞȜȚșȓȠȣțĮȚįȚĮĲȓșİĲĮȚȝİʌȜȒȡȘȕȠȘșȘĲȚțȐİȟĮȡĲȒȝĮĲĮȖȚĮĲȡȠĳȠįȠıȓĮȝİ İȞĮȜȜĮııȩȝİȞȠȡİȪȝĮțĮșȫȢțĮȚșȒțȘȝİĲĮĳȠȡȐȢȅțĮșİĲȒȡĮȢȕȚȠȥȓĮȢĮʌȠĲİȜİȓĲĮȚĮʌȩ ȝȚĮțȠȓȜȘİȟȦĲİȡȚțȒțȩʌĲȠȣıĮțȐȞȠȣȜĮȝȚĮİıȦĲİȡȚțȒȕİȜȩȞĮȝİșȐȜĮȝȠįİȚȖȝĮĲȠȜȘȥȓĮȢ ʌȠȣĳȑȡİȚİȖțȠʌȒțĮȚȝȚĮİȞıȦȝĮĲȦȝȑȞȘȠȝȠĮȟȠȞȚțȒțȐȞȠȣȜĮǾİȟȦĲİȡȚțȒțȐȞȠȣȜĮțĮȚȘ İȞıȦȝĮĲȦȝȑȞȘȠȝȠĮȟȠȞȚțȒțȐȞȠȣȜĮȑȤȠȣȞĮȚȤȝȘȡȑȢĮțȝȑȢțȠʌȒȢțĮȚȘİıȦĲİȡȚțȒȕİȜȩȞĮ ȑȤİȚȑȞĮĮȚȤȝȘȡȩȐțȡȠĲȡȠțȐȡȅȠįȘȖȩȢȤȡȘıȚȝȠʌȠȚİȓțȚȞȘĲȒȡİȢʌȠȣȜİȚĲȠȣȡȖȠȪȞȝİıȣȞİȤȑȢ ȡİȪȝĮʌȡȠțİȚȝȑȞȠȣȞĮįȘȝȚȠȣȡȖȘșİȓțİȞȩİȞȫĲĮȣĲȩȤȡȠȞĮȝİĲĮțȚȞİȓĲȘȞİȟȦĲİȡȚțȒțȐȞȠȣȜĮ ʌȡȠȢĲĮʌȓıȦʌȡȠțİȚȝȑȞȠȣȞĮĮʌȠțĮȜȣĳșİȓȠșȐȜĮȝȠȢįİȚȖȝĮĲȠȜȘȥȓĮȢțĮȚȞĮĮȞĮȡȡȠĳȒıİȚ ȚıĲȩǾİȟȦĲİȡȚțȒțȐȞȠȣȜĮĮʌİȜİȣșİȡȫȞİĲĮȚțĮȚȝİĲĮțȚȞİȓĲĮȚʌȡȠȢĲĮİȝʌȡȩȢʌȐȞȦĮʌȩĲȠ șȐȜĮȝȠįİȚȖȝĮĲȠȜȘȥȓĮȢȖȚĮȞĮĮʌȠțȩȥİȚĲȠȞȚıĲȩȉȠįİȓȖȝĮȚıĲȠȪȝİĲĮĳȑȡİĲĮȚȝȑıȦĲȠȣ șĮȜȐȝȠȣįİȚȖȝĮĲȠȜȘȥȓĮȢıĲȠȞȣʌȠįȠȤȑĮįİȚȖȝȐĲȦȞȅșȐȜĮȝȠȢįİȚȖȝĮĲȠȜȘȥȓĮȢİʌȚıĲȡȑĳİȚ ıĲȘȞĮȡȤȚțȒșȑıȘțĮȚİȓȞĮȚįȚĮșȑıȚȝȠȢȖȚĮĲȘȜȒȥȘİȞȩȢȐȜȜȠȣįİȓȖȝĮĲȠȢǾİȞıȦȝĮĲȦȝȑȞȘ ȠȝȠĮȟȠȞȚțȒțȐȞȠȣȜĮȝʌȠȡİȓȞĮĮʌȠțȠȜȜȘșİȓȝİĲȐĲȘȕȚȠȥȓĮțĮȚȞĮʌĮȡĮȝİȓȞİȚıĲȠȝĮıĲȩ ȫıĲİȞĮįȚĮĲȘȡȒıİȚȝȚĮįȓȠįȠʌȡȠȢĲȠıȘȝİȓȠĲȘȢȕȚȠȥȓĮȢİȐȞʌȡȩțİȚĲĮȚȞĮĲȠʌȠșİĲȘșİȓȑȞĮȢ įİȓțĲȘȢȚıĲȠȪ ȈǾȂǼǿȍȈǾǾİȞıȦȝĮĲȦȝȑȞȘȠȝȠĮȟȠȞȚțȒțȐȞȠȣȜĮʌȡȑʌİȚȞĮʌĮȡĮȝȑȞİȚ ʌȡȠıĮȡĲȘȝȑȞȘțĮĲȐĲȘȜȒȥȘįİȚȖȝȐĲȦȞȚıĲȠȪ A B C D

ǹȡȚșȝȩȢ țĮĲĮȜȩȖȠȣ

ȆİȡȚȖȡĮĳȒ

ȂȑȖİșȠȢ ıİJDXJH

F14105US

ȀĮșİĲȒȡĮȢȕȚȠȥȓĮȢ ȝİȣʌİȡȒȤȠȣȢ

14G

105mm

17mm

7mm

20mm

F10105US

ȀĮșİĲȒȡĮȢȕȚȠȥȓĮȢ ȝİȣʌİȡȒȤȠȣȢ

10G

105mm

21mm

9mm

20mm

% ǼȞįİȓȟİȚȢȤȡȒıȘȢ ȉȠıȪıĲȘȝĮȕȚȠȥȓĮȢȝĮıĲȠȪFINESSE® 8OWUDİȞįİȓțȞȣĲĮȚȖȚĮĲȘȜȒȥȘįİȚȖȝȐĲȦȞȚıĲȠȪĮʌȩĲȠ ȝĮıĲȩȒĲȠȣȢȝĮıȤĮȜȚĮȓȠȣȢȜİȝĳĮįȑȞİȢȖȚĮĲȘįȚĮȖȞȦıĲȚțȒĮȞȐȜȣıȘĮȞȦȝĮȜȚȫȞĲȠȣȝĮıĲȠȪ ȉȠİȡȖĮȜİȓȠʌȡȠȠȡȓȗİĲĮȚȖȚĮĲȘȞʌĮȡȠȤȒȝĮıĲȚțȠȪȚıĲȠȪȖȚĮȚıĲȠȜȠȖȚțȒİȟȑĲĮıȘȝİȝİȡȚțȒ ȒʌȜȒȡȘĮĳĮȓȡİıȘĲȘȢĮʌİȚțȠȞȚȗȩȝİȞȘȢĮȞȦȝĮȜȓĮȢ ȉȠİȪȡȠȢĲȘȢȚıĲȠȜȠȖȚțȒȢĮȞȦȝĮȜȓĮȢįİȞȝʌȠȡİȓȞĮʌȡȠıįȚȠȡȚıĲİȓȝİĮȟȚȠʌȚıĲȓĮȕȐıİȚ ĲȘȢȝĮıĲȠȖȡĮĳȚțȒȢİȝĳȐȞȚıȘȢȀĮĲȐıȣȞȑʌİȚĮĲȠİȪȡȠȢĮĳĮȓȡİıȘȢĲȠȣĮʌİȚțȠȞȚıșȑȞĲȠȢ ıĲȠȚȤİȓȠȣĮȞȦȝĮȜȓĮȢįİȞĮʌȠĲİȜİȓʌĮȡȐȖȠȞĲĮʌȡȩȕȜİȥȘȢĲȠȣİȪȡȠȣȢĮĳĮȓȡİıȘȢȝȚĮȢ ȚıĲȠȜȠȖȚțȒȢĮȞȦȝĮȜȓĮȢ ʌȤĲȘȢțĮțȠȒșİȚĮȢ ǵĲĮȞȘįİȚȖȝĮĲȠȜȘĳșİȓıĮĮȞȦȝĮȜȓĮįİȞ İȓȞĮȚȚıĲȠȜȠȖȚțȐțĮȜȠȒșȘȢİȓȞĮȚĮʌĮȡĮȓĲȘĲȠĲĮȩȡȚĮĲȠȣȩȖțȠȣȞĮİȟİĲĮıĲȠȪȞıİȩ ĲȚĮĳȠȡȐĲȘȞʌȜȘȡȩĲȘĲĮĲȘȢĮĳĮȓȡİıȘȢȝİĲȘȤȡȒıȘĲȣʌȚțȫȞȤİȚȡȠȣȡȖȚțȫȞİʌİȝȕȐıİȦȞ & ǹȞĲİȞįİȓȟİȚȢ 1. ȉȠıȪıĲȘȝĮȕȚȠȥȓĮȢȝĮıĲȠȪFINESSE® 8OWUDȤȡȘıȚȝȠʌȠȚİȓĲĮȚĮʌȠțȜİȚıĲȚțȐȖȚĮįȚĮȖȞȦıĲȚțȒ ȤȡȒıȘȅȋǿȖȚĮșİȡĮʌİȣĲȚțȒȤȡȒıȘ 2. ȉȠıȪıĲȘȝĮȕȚȠȥȓĮȢȝĮıĲȠȪFINESSE® 8OWUDĮȞĲİȞįİȓțȞȣĲĮȚıİĮıșİȞİȓȢȠȚȠʌȠȓȠȚ ıȪȝĳȦȞĮȝİĲȘȞțȡȓıȘĲȠȣȚĮĲȡȠȪįȚĮĲȡȑȤȠȣȞĮȣȟȘȝȑȞȠțȓȞįȣȞȠİʌȚʌȜȠțȫȞʌȠȣ ıȤİĲȓȗȠȞĲĮȚȝİĲȘįȚĮįİȡȝȚțȒĮĳĮȓȡİıȘįİȚȖȝȐĲȦȞȚıĲȠȪ ' ȆȡȠİȚįȠʌȠȚȒıİȚȢ ȅȚĮıșİȞİȓȢȠȚȠʌȠȓȠȚİȞįȑȤİĲĮȚȞĮȑȤȠȣȞįȚĮĲĮȡĮȤȒĲȘȢʌȒȟȘȢĲȠȣĮȓȝĮĲȠȢ ȒȠȚȠʌȠȓȠȚȜĮȝȕȐȞȠȣȞĮȞĲȚʌȘțĲȚțȒșİȡĮʌİȓĮʌȚșĮȞȩȞȞĮįȚĮĲȡȑȤȠȣȞĮȣȟȘȝȑȞȠ țȓȞįȣȞȠİʌȚʌȜȠțȫȞ ǵʌȦȢȝİȩȜĮĲĮİȡȖĮȜİȓĮȕȚȠȥȓĮȢȣʌȐȡȤİȚʌȚșĮȞȩĲȘĲĮȜȠȓȝȦȟȘȢ ȂȘȞİʌĮȞĮȤȡȘıȚȝȠʌȠȚİȓĲİĲȠȣȢțĮșİĲȒȡİȢȕȚȠȥȓĮȢFINESSE® Ultra. ǾİʌĮȞĮȤȡȘıȚȝȠʌȠȓȘıȘĲȠȣțĮșİĲȒȡĮİȞȑȤİȚĲȠȞțȓȞįȣȞȠȝȩȜȣȞıȘȢĲȠȣĮıșİȞȒ ĮʌȩȐȜȜȠȞĮıșİȞȒțĮșȫȢȠȚțĮșİĲȒȡİȢȕȚȠȥȓĮȢİȚįȚțȩĲİȡĮİțİȓȞȠȚȝİȝĮțȡȚȠȪȢ țĮȚıĲİȞȠȪȢĮȣȜȠȪȢıȣȞįȑıİȚȢțĮȚȒıȤȚıȝȑȢȝİĲĮȟȪĲȦȞİȟĮȡĲȘȝȐĲȦȞİȓȞĮȚ įȪıțȠȜȠȒĮįȪȞĮĲȠȞȞĮțĮșĮȡȚıĲȠȪȞĮʌȩĲȘıĲȚȖȝȒʌȠȣıȦȝĮĲȚțȐȣȖȡȐȒ ȚıĲȠȓȝİʌȚșĮȞȒʌȣȡİĲȠȖȩȞȠȒȝȚțȡȠȕȚĮțȒİʌȚȝȩȜȣȞıȘȑȤȠȣȞȑȡșİȚıİİʌĮĳȒȝİ ĲȠȞțĮșİĲȒȡĮȖȚĮȠʌȠȚĮįȒʌȠĲİȤȡȠȞȚțȒʌİȡȓȠįȠȉĮțĮĲȐȜȠȚʌĮĲȦȞȕȚȠȜȠȖȚțȫȞ ȣȜȚțȫȞȝʌȠȡȠȪȞȞĮʌȡȠȐȖȠȣȞĲȘȞİʌȚȝȩȜȣȞıȘĲȠȣțĮșİĲȒȡĮȝİʌȣȡİĲȠȖȩȞĮ ȒȝȚțȡȠȠȡȖĮȞȚıȝȠȪȢȠȚȠʌȠȓȠȚİȞįȑȤİĲĮȚȞĮʌȡȠțĮȜȑıȠȣȞȜȠȚȝȫįİȚȢİʌȚʌȜȠțȑȢ ȂȘȞİʌĮȞĮʌȠıĲİȚȡȫȞİĲİĲȠȣȢțĮșİĲȒȡİȢȕȚȠȥȓĮȢFINESSE® 8OWUDȂİĲȐĮʌȩĲȘȞ İʌĮȞĮʌȠıĲİȓȡȦıȘȘıĲİȚȡȩĲȘĲĮĲȠȣțĮșİĲȒȡĮįİȞİȓȞĮȚİȖȖȣȘȝȑȞȘȜȩȖȦĲȘȢ ʌĮȡȠȣıȓĮȢĮʌȡȠıįȚȩȡȚıĲȠȣȕĮșȝȠȪʌȚșĮȞȒȢʌȣȡİĲȠȖȩȞȠȣȒȝȚțȡȠȕȚĮțȒȢ İʌȚȝȩȜȣȞıȘȢȘȠʌȠȓĮȝʌȠȡİȓȞĮʌȡȠțĮȜȑıİȚȜȠȚȝȫįİȚȢİʌȚʌȜȠțȑȢȅțĮșĮȡȚıȝȩȢ ȘİʌĮȞİʌİȟİȡȖĮıȓĮțĮȚȒȘİʌĮȞĮʌȠıĲİȓȡȦıȘĲȠȣțĮșİĲȒȡĮĮȣȟȐȞİȚĲȘȞʌȚșĮȞȩĲȘĲĮ İıĳĮȜȝȑȞȘȢȜİȚĲȠȣȡȖȓĮȢĲȠȣȜȩȖȦʌȚșĮȞȫȞĮȞİʌȚșȪȝȘĲȦȞİȞİȡȖİȚȫȞʌȠȣȝʌȠȡİȓ ȞĮʌȡȠțĮȜȑıȠȣȞıĲĮİȟĮȡĲȒȝĮĲĮȠȚșİȡȝȚțȑȢțĮȚȒȠȚȝȘȤĮȞȚțȑȢȝİĲĮȕȠȜȑȢ ȅțĮșİĲȒȡĮȢȕȚȠȥȓĮȢFINESSE® 8OWUDʌȡȑʌİȚȞĮȤȡȘıȚȝȠʌȠȚİȓĲĮȚȝȩȞȠȝİĲȠȞȠįȘȖȩ ȕȚȠȥȓĮȢFINESSE® Ultra. ǵȜİȢȠȚȕȚȠȥȓİȢȝĮıĲȠȪșĮʌȡȑʌİȚȞĮįȚİȞİȡȖȠȪȞĲĮȚȝİĮʌİȚțȠȞȚıĲȚțȒțĮșȠįȒȖȘıȘ ȘȠʌȠȓĮșĮİʌȚȕİȕĮȚȫȞİȚĲȘșȑıȘĲȠȣțĮșİĲȒȡĮıİıȤȑıȘȝİĲȘȞʌİȡȚȠȤȒıĲȩȤȠ ȩʌȠȣʌȡȩțİȚĲĮȚȞĮȖȓȞİȚȘįİȚȖȝĮĲȠȜȘȥȓĮțĮȚșĮȣʌȠȕȠȘșȐıĲȠȞʌİȡȚȠȡȚıȝȩ ĲȘȢʌȚșĮȞȩĲȘĲĮȢİȝĳȐȞȚıȘȢȥİȣįȫȢĮȡȞȘĲȚțȒȢȕȚȠȥȓĮȢȅțĮșİĲȒȡĮȢȕȚȠȥȓĮȢ FINESSE® 8OWUDʌȡȠȠȡȓȗİĲĮȚĮʌȠțȜİȚıĲȚțȐȖȚĮȤȡȒıȘȝİĮʌİȚțȩȞȚıȘȣʌİȡȒȤȦȞ ǼȆȡȠĳȣȜȐȟİȚȢ ȂȘȤȡȘıȚȝȠʌȠȚİȓĲİĲȠȞțĮșİĲȒȡĮȕȚȠȥȓĮȢFINESSE® 8OWUDȤȦȡȓȢĲȘȞİȞıȦȝĮĲȦȝȑȞȘ ȠȝȠĮȟȠȞȚțȒțȐȞȠȣȜĮǾİȞıȦȝĮĲȦȝȑȞȘȠȝȠĮȟȠȞȚțȒțȐȞȠȣȜĮȝʌȠȡİȓȞĮĮĳĮȚȡİșİȓȝİĲȐ ĲȘȕȚȠȥȓĮȫıĲİȞĮįȚĮĲȘȡȒıİȚȝȚĮįȓȠįȠʌȡȠȢĲȠıȘȝİȓȠĲȘȢȕȚȠȥȓĮȢİȐȞʌȡȩțİȚĲĮȚȞĮ ĲȠʌȠșİĲȘșİȓȑȞĮȢįİȓțĲȘȢȚıĲȠȪ 22

20mm

ȈǾȂǼǿȍȈǾȅȠįȘȖȩȢįİȞʌİȡȚȑȤİȚįȚĮțȩʌĲȘİȞİȡȖȠʌȠȓȘıȘȢĮʌİȞİȡȖȠʌȠȓȘıȘȢ ȅȠįȘȖȩȢĮȞĮȖȞȦȡȓȗİȚĮȣĲȩȝĮĲĮĲȠȞĲȪʌȠĲȠȣțĮșİĲȒȡĮĮȞȚȤȞİȪİȚʌȩĲİȠțĮșİĲȒȡĮȢ ȑȤİȚİȚıĮȤșİȓıȦıĲȐțĮȚʌȡȠİĲȠȚȝȐȗİĲĮȚȖȚĮĲȠıȣȖȤȡȠȞȚıȝȩĲȠȣȠįȘȖȠȪțĮȚĲȠȣțĮșİĲȒȡĮ ȅȠįȘȖȩȢİțʌȑȝʌİȚĲȡİȚȢıȪȞĲȠȝȠȣȢȒȤȠȣȢțĮȚȠȚİȞįİȚțĲȚțȑȢȜȣȤȞȓİȢ35,0(3,(5&( ȆȇȅǼȉȅǿȂǹȈǿǹǻǿǹȉȇǾȈǾ țĮȚ6$03/( ǻǼǿīȂǹȉȅȁǾȌǿǹ ĮȞȐȕȠȣȞȝİʌȡȐıȚȞȠ ĳȦȢȣʌȠįİȚțȞȪȠȞĲĮȢȩĲȚȠțĮșİĲȒȡĮȢȑȤİȚİȚıĮȤșİȓıȦıĲȐȀĮĲȐĲȘįȚȐȡțİȚĮĲȘȢ ȜİȚĲȠȣȡȖȓĮȢȑȞĮȡȟȘȢĮțȠȪȖİĲĮȚȠȒȤȠȢĲȠȣțȚȞȘĲȒȡĮ ǹĳȠȪȠȜȠțȜȘȡȦșİȓȘʌȡȠİĲȠȚȝĮıȓĮĮĳĮȚȡȑıĲİĲȠʌȡȠıĲĮĲİȣĲȚțȩțȐȜȣȝȝĮĮʌȩĲȠȞ țĮșİĲȒȡĮ ȈǾȂǼǿȍȈǾīȚĮıȘȝĮȞĲȚțȑȢʌȜȘȡȠĳȠȡȓİȢıȤİĲȚțȐȝİĲȘȜİȚĲȠȣȡȖȓĮĲȠȣȠįȘȖȠȪ ĮȞĮĲȡȑȟĲİıĲȚȢȠįȘȖȓİȢȤȡȒıȘȢĲȠȣȠįȘȖȠȪȕȚȠȥȓĮȢFINESSE® Ultra. ǻȚİȞȑȡȖİȚĮȕȚȠȥȓĮȢ ȆȡȠİĲȠȚȝȐıĲİĲȠıȘȝİȓȠĲȘȢȕȚȠȥȓĮȢȤȡȘıȚȝȠʌȠȚȫȞĲĮȢțĮĲȐȜȜȘȜİȢȐıȘʌĲİȢĲİȤȞȚțȑȢțĮȚ İʌĮȡțȒĲȠʌȚțȒĮȞĮȚıșȘıȓĮȈİțȐșİįȚĮįİȡȝȚțȒįȚĮįȚțĮıȓĮșĮʌȡȑʌİȚȞĮȜĮȝȕȐȞȠȞĲĮȚ ȠȚțĮĲȐȜȜȘȜİȢʌȡȠĳȣȜȐȟİȚȢ șĮʌȡȑʌİȚȞĮȤȡȘıȚȝȠʌȠȚİȓĲĮȚʌȡȠıȦʌȚțȩȢİȟȠʌȜȚıȝȩȢ ʌȡȠıĲĮıȓĮȢȩʌȦȢȖȐȞĲȚĮțĮȚȖȣĮȜȚȐʌȡȠıĲĮĲİȣĲȚțȐțȜʌ ȀȐȞĲİȝȚĮȝȚțȡȒĲȠȝȒȒȞȣȖȝȩĲȠȣįȑȡȝĮĲȠȢȝİȑȞĮȞȣıĲȑȡȚ ȋȡȘıȚȝȠʌȠȚȫȞĲĮȢțĮșȠįȒȖȘıȘȣʌİȡȒȤȦȞİȚıĮȖȐȖİĲİĲȠȞțĮșİĲȒȡĮȝȑıĮĮʌȩĲȘȞĲȠȝȒ țĮȚĲȠʌȠșİĲȒıĲİĲȠȐțȡȠĲȘȢıĲȠțĮĲȐȜȜȘȜȠȕȐșȠȢ ǼȐȞʌȡȩțİȚĲĮȚȞĮįȚĮĲȡȘșİȓ ǼȚțȩȞĮ ȘȕȜȐȕȘȉȠʌȠșİĲȒıĲİ ĲȠȐțȡȠĲȠȣțĮșİĲȒȡĮ țİȞĲȡȚțȩĲİȡĮĮʌȩĲȠ ȀȠȣȝʌȓ ȤİȓȜȠȢĲȘȢȕȜȐȕȘȢ ȀȠȣȝʌȓ PRIME/PIERCE ǼȐȞįİȞʌȡȩțİȚĲĮȚ SAMPLE ȆȡȠİĲȠȚȝĮıȓĮ ǻİȚȖȝĮĲȠȜȘȥȓĮ ȞĮįȚĮĲȡȘșİȓȘȕȜȐȕȘ ǻȚȐĲȡȘıȘ ȉȠʌȠșİĲȒıĲİĲȠșȐȜĮȝȠ PRIME/ SAMPLE įİȚȖȝĮĲȠȜȘȥȓĮȢıĲȠțȑȞĲȡȠ PIERCE ĲȘȢʌİȡȚȠȤȒȢıĲȩȤȠȣ ȉȠțȑȞĲȡȠĲȠȣșĮȜȐȝȠȣ įİȚȖȝĮĲȠȜȘȥȓĮȢȕȡȓıțİĲĮȚʌİȡȓʌȠȣPPĮʌȩĲȠȐțȡȠĲȠȣțĮșİĲȒȡĮ ǼȐȞİʌȚșȣȝİȓĲİĲȘįȚȐĲȡȘıȘʌȡȠĲȠȪİȚıȐȖİĲİĲȠȞțĮșİĲȒȡĮıĲȠȝĮıĲȩʌȚȑıĲİĲȠțȠȣȝʌȓ “PRIME/PIERCE” ȆȇȅǼȉȅǿȂǹȈǿǹǻǿǹȉȇǾȈǾ ȖȚĮȞĮĮʌȠıȪȡİĲİĲȠȞțĮșİĲȒȡĮ țĮĲȐPPǹĳȠȪİȚıĮȖȐȖİĲİĲȠȞțĮșİĲȒȡĮʌȚȑıĲİĲȠțȠȣȝʌȓ“PRIME/PIERCE” ȆȇȅǼȉȅǿȂǹȈǿǹǻǿǹȉȇǾȈǾ ȖȚĮȞĮʌȡȠȦșȒıİĲİĲȠȞțĮșİĲȒȡĮțĮĲȐPP ıĲȘȞʌİȡȚȠȤȒİȞįȚĮĳȑȡȠȞĲȠȢʌȡȚȞĮʌȩĲȘȜȒȥȘĲȠȣʌȡȫĲȠȣįİȓȖȝĮĲȠȢȚıĲȠȪ ǼȚțȩȞĮ ȈǾȂǼǿȍȈǾĬĮʌȡȑʌİȚȞĮȤȡȘıȚȝȠʌȠȚİȓĲĮȚĮʌİȚțȠȞȚıĲȚțȒțĮșȠįȒȖȘıȘȫıĲİȞĮ İʌȚȕİȕĮȚȫȞİĲĮȚȘșȑıȘĲȠȣțĮșİĲȒȡĮıȤİĲȚțȐȝİĲȘȞʌİȡȚȠȤȒıĲȩȤȠʌȠȣʌȡȩțİȚĲĮȚ ȞĮȖȓȞİȚȘįİȚȖȝĮĲȠȜȘȥȓĮ ȈǾȂǼǿȍȈǾȀĮĲȐĲȘȞĮȡȤȚțȒĲȠʌȠșȑĲȘıȘĲȠȣțĮșİĲȒȡĮıȣȞȚıĲȐĲĮȚȞĮʌȡȠȦșİȓĲİ ĲȠȞțĮșİĲȒȡĮȝȑıĮıĲȠȞȚıĲȩȤȡȘıȚȝȠʌȠȚȫȞĲĮȢĲȘȞİʌȚȜȠȖȒ³35,0(3,(5&(´ ȆȇȅǼȉȅǿȂǹȈǿǹǻǿǹȉȇǾȈǾ ȈĲȚȢİʌĮțȩȜȠȣșİȢįİȚȖȝĮĲȠȜȘȥȓİȢȠȚĮĲȡȩȢȝʌȠȡİȓ İȐȞĲȠİʌȚșȣȝİȓȞĮʌĮȡĮȜİȓȥİȚĮȣĲȩĲȠȕȒȝĮ ȈǾȂǼǿȍȈǾȈĲȘȞʌİȡȓʌĲȦıȘʌȠȣİȓȞĮȚİʌȚșȣȝȘĲȑȢțĮȚȐȜȜİȢȕȠȜȑȢįȚȐĲȡȘıȘȢȖȚĮĲȘȞ ʌȡȩıȕĮıȘıİʌȣțȞȠȪȢȚıĲȠȪȢȒıİȕȜȐȕİȢȠțĮșİĲȒȡĮȢİȓȞĮȚįȣȞĮĲȩȞĮʌȜȘȡȦșİȓȖȚĮ įȚȐĲȡȘıȘİȞȩıȦȕȡȓıțİĲĮȚİȞĲȩȢĲȠȣĮıșİȞȒ ȄİțȚȞȒıĲİĲȘįİȚȖȝĮĲȠȜȘȥȓĮȚıĲȠȪʌȚȑȗȠȞĲĮȢĲȠțȠȣȝʌȓ“SAMPLE” ǻǼǿīȂǹȉȅȁǾȌǿǹ ǾįȚĮįȚțĮıȓĮįİȚȖȝĮĲȠȜȘȥȓĮȢȟİțȚȞȐİȚĮȣĲȩȝĮĲĮǻȘȝȚȠȣȡȖİȓĲĮȚțİȞȩȘİȟȦĲİȡȚțȒ țȐȞȠȣȜĮĲȠȣțĮșİĲȒȡĮĮʌȠıȪȡİĲĮȚĮȣĲȩȝĮĲĮȠȚıĲȩȢĮȞĮȡȡȠĳȐĲĮȚȜȩȖȦĲȠȣțİȞȠȪıĲȠ șȐȜĮȝȠįİȚȖȝĮĲȠȜȘȥȓĮȢțĮȚĮʌİȜİȣșİȡȫȞİĲĮȚȘİȟȦĲİȡȚțȒțȐȞȠȣȜĮĮʌȠțȩʌĲȠȞĲĮȢĲȠȞ ȚıĲȩȈĲȘıȣȞȑȤİȚĮĲȠįİȓȖȝĮĲȠȣȚıĲȠȪȝİĲĮĳȑȡİĲĮȚıĲȠȞȣʌȠįȠȤȑĮįİȚȖȝȐĲȦȞȀĮĲȐĲȘ įȚȐȡțİȚĮĮȣĲȒȢĲȘȢįȚĮįȚțĮıȓĮȢȘİȞįİȚțĲȚțȒȜȣȤȞȓĮ“SAMPLE” ǻǼǿīȂǹȉȅȁǾȌǿǹ İȓȞĮȚ ıȣȞİȤȫȢĮȞĮȝȝȑȞȘȝİʌȠȡĲȠțĮȜȓĳȦȢțĮȚĮțȠȪȖİĲĮȚȠȒȤȠȢĲȠȣțȚȞȘĲȒȡĮȅȣʌȠįȠȤȑĮȢ įİȚȖȝȐĲȦȞĳȦĲȓȗİĲĮȚȫıĲİȞĮȣʌȠȕȠȘșȒıİȚıĲȘȞʌĮȡĮĲȒȡȘıȘĲȠȣįİȓȖȝĮĲȠȢȚıĲȠȪȂİĲȐ 23

ǼȁȁǾȃǿȀǹ

ȉȠıȪıĲȘȝĮȕȚȠȥȓĮȢȝĮıĲȠȪFINESSE® 8OWUDșĮʌȡȑʌİȚȞĮȤȡȘıȚȝȠʌȠȚİȓĲĮȚȝȩȞȠȞĮʌȩ ȚĮĲȡȠȪȢİțʌĮȚįİȣȝȑȞȠȣȢıĲȘȤȡȒıȘȖȚĮĲȘȞȠʌȠȓĮİȞįİȓțȞȣĲĮȚıĲȠȣȢʌİȡȚȠȡȚıȝȠȪȢțĮȚ ıĲȚȢʌȚșĮȞȑȢİʌȚʌȜȠțȑȢĲȦȞĲİȤȞȚțȫȞĲȦȞįȚĮįİȡȝȚțȫȞİʌİȝȕȐıİȦȞȝİȕİȜȩȞĮ ) ǻȣȞȘĲȚțȑȢİʌȚʌȜȠțȑȢ 1. ǻȣȞȘĲȚțȑȢİʌȚʌȜȠțȑȢİȓȞĮȚĮȣĲȑȢʌȠȣıȤİĲȓȗȠȞĲĮȚȝİȩȜİȢĲȚȢįȚĮįİȡȝȚțȑȢĲİȤȞȚțȑȢ ĮĳĮȓȡİıȘȢȕȚȠȥȓĮȢȖȚĮĲȘıȣȜȜȠȖȒȚıĲȠȪȅȚįȣȞȘĲȚțȑȢİʌȚʌȜȠțȑȢʌİȡȚȠȡȓȗȠȞĲĮȚ ıĲȘȞʌİȡȚȠȤȒʌȠȣʌİȡȚȕȐȜȜİȚĲȠıȘȝİȓȠĲȘȢȕȚȠȥȓĮȢțĮȚʌİȡȚȜĮȝȕȐȞȠȣȞĲȠĮȚȝȐĲȦȝĮ ĲȘȞĮȚȝȠȡȡĮȖȓĮĲȘȜȠȓȝȦȟȘĲȘȝȘİʌȠȪȜȦıȘĲȠȣĲȡĮȪȝĮĲȠȢĲȠȐȜȖȠȢțĮȚĲȘȞ ʌȡȠıțȩȜȜȘıȘȚıĲȠȪıĲȠȞțĮșİĲȒȡĮȕȚȠȥȓĮȢțĮĲȐĲȘȞĮĳĮȓȡİıȒĲȘȢĮʌȩĲȠȝĮıĲȩ 2. ǵʌȦȢțĮȚȝİĲȚȢıȣȞȒșİȚȢįȚĮįȚțĮıȓİȢȕȚȠȥȓĮȢİȞįȑȤİĲĮȚȞĮĮʌĮȚĲȘșİȓȘĮʌȠțȠʌȒȚıĲȠȪ ʌȠȣȑȤİȚʌȡȠıțȠȜȜȘșİȓıĲȠȞțĮșİĲȒȡĮȕȚȠȥȓĮȢțĮĲȐĲȘȞĮĳĮȓȡİıȒĲȘȢĮʌȩĲȠȝĮıĲȩ * ǹʌĮȚĲȠȪȝİȞȠȢİȟȠʌȜȚıȝȩȢ īȚĮĲȘįȚĮįȚțĮıȓĮĲȘȢȕȚȠȥȓĮȢĮʌĮȚĲİȓĲĮȚȠʌĮȡĮțȐĲȦİȟȠʌȜȚıȝȩȢ ȀĮĲȐȜȜȘȜȘȝȑșȠįȠȢĮʌİȚțȩȞȚıȘȢțĮȚȕȠȘșȘĲȚțȐİȟĮȡĲȒȝĮĲĮ ȅįȘȖȩȢȕȚȠȥȓĮȢFINESSE® Ultra ȀĮșİĲȒȡĮȢȕȚȠȥȓĮȢFINESSE® Ultra ȋİȚȡȠȣȡȖȚțȐȖȐȞĲȚĮțĮȚȚȝȐĲȚĮ ȉȠʌȚțȩĮȞĮȚıșȘĲȚțȩ ȃȣıĲȑȡȚ ǱȜȜȠȢİȟȠʌȜȚıȝȩȢȩʌȦȢİȓȞĮȚĮʌĮȡĮȓĲȘĲȠ + ȅįȘȖȓİȢȤȡȒıȘȢ ȉȠʌȠșȑĲȘıȘĲȠȣțĮșİĲȒȡĮıĲȠȞȠįȘȖȩ ǺİȕĮȚȦșİȓĲİȩĲȚȠȠįȘȖȩȢȑȤİȚĳȠȡĲȚıĲİȓʌȜȒȡȦȢȂİĲȐĮʌȩĲȘȞțĮșȘȝİȡȚȞȒȤȡȒıȘ ȠȠįȘȖȩȢșĮʌȡȑʌİȚȞĮĳȠȡĲȓȗİĲĮȚțĮĲȐĲȘįȚȐȡțİȚĮĲȘȢȞȪȤĲĮȢ ǹĳĮȚȡȑıĲİĲȠȞțĮșİĲȒȡĮĮʌȩĲȘıȣıțİȣĮıȓĮȝİȤȡȒıȘȐıȘʌĲȘȢĲİȤȞȚțȒȢțȡĮĲȫȞĲĮȢ ĲȠȞțĮșİĲȒȡĮĮʌȩĲȠțȐĲȦȝȑȡȠȢĲȠȣǺİȕĮȚȦșİȓĲİȩĲȚȠțĮșİĲȒȡĮȢʌĮȡĮȝȑȞİȚıĲİȓȡȠȢ ǼȚıȐȖİĲİĲȠȞțĮșİĲȒȡĮȝȑıĮıĲȠȞȠįȘȖȩ ǼȚțȩȞĮ ǹĳĮȚȡȑıĲİĲȘȞțĮȡĳȓįĮıȣȖțȡȐĲȘıȘȢ ǼȚțȩȞĮ ȈȪȡİĲİĲȠĳȠȡȑĮĲȠȣțĮșİĲȒȡĮʌȡȠȢĲĮʌȓıȦįȚĮıĳĮȜȓȗȠȞĲĮȢȩĲȚȘȖȜȦĲĲȓįĮȑȤİȚ ĮıĳĮȜȓıİȚțĮȜȐıĲȘșȑıȘĲȘȢ ǼȚțȩȞĮ ǼȚțȩȞĮ ǼȚțȩȞĮ ǼȚțȩȞĮ

ǼȁȁǾȃǿȀȺ

ĲȘȞİȞĮʌȩșİıȘĲȠȣįİȓȖȝĮĲȠȢȚıĲȠȪıĲȠȞȣʌȠįȠȤȑĮįİȚȖȝȐĲȦȞȖȓȞİĲĮȚİʌĮȞĮĳȠȡȐĲȠȣ ıȣıĲȒȝĮĲȠȢȖȚĮĲȘȜȒȥȘțĮȚȐȜȜȠȣįİȓȖȝĮĲȠȢİȐȞĲȠİʌȚșȣȝİȓĲİ ȈǾȂǼǿȍȈǾȂȘȞʌȚȑȗİĲİĲȠȞȣʌȠįȠȤȑĮįİȚȖȝȐĲȦȞțĮȚȝȘȞĮĳĮȚȡİȓĲİĲȠȞȣʌȠįȠȤȑĮ įİȚȖȝȐĲȦȞțĮĲȐĲȘȜȒȥȘįİȚȖȝȐĲȦȞȚıĲȫȞ īȚĮĲȘȜȒȥȘʌȠȜȜĮʌȜȫȞįİȚȖȝȐĲȦȞİʌĮȞĮȜȐȕİĲİĲȠʌĮȡĮʌȐȞȦȕȒȝĮ ȈǾȂǼǿȍȈǾǾıȣȜȜȠȖȒʌȠȜȜĮʌȜȫȞįİȚȖȝȐĲȦȞȚıĲȠȪİȞįȑȤİĲĮȚȞĮȝİȚȫıİȚĲȠȞțȓȞįȣȞȠ ȥİȣįȫȢĮȡȞȘĲȚțȒȢȕȚȠȥȓĮȢ ȂİĲȐĮʌȩĲȘȜȒȥȘĲȠȣĲİȜİȣĲĮȓȠȣįİȓȖȝĮĲȠȢȚıĲȠȪĮĳĮȚȡȑıĲİĲȠȞțĮșİĲȒȡĮĮʌȩĲȠ ȝĮıĲȩțĮȚĳȡȠȞĲȓıĲİĲȠıȘȝİȓȠĲȠȝȒȢȩʌȦȢĮʌĮȚĲİȓĲĮȚ ȈǾȂǼǿȍȈǾȆȡȚȞĮʌȩĲȘȞĮĳĮȓȡİıȘĲȠȣțĮșİĲȒȡĮĮʌȩĲȠȝĮıĲȩȘİȞıȦȝĮĲȦȝȑȞȘ ȠȝȠĮȟȠȞȚțȒțȐȞȠȣȜĮȝʌȠȡİȓȞĮĮʌȠțȠȜȜȘșİȓțĮȚȞĮʌĮȡĮȝİȓȞİȚıĲȠȝĮıĲȩȫıĲİȞĮ įȚĮĲȘȡȒıİȚȝȚĮįȓȠįȠʌȡȠȢĲȠıȘȝİȓȠĲȘȢȕȚȠȥȓĮȢİȐȞʌȡȩțİȚĲĮȚȞĮĲȠʌȠșİĲȘșİȓȑȞĮȢ įİȓțĲȘȢȚıĲȠȪ ǼȚțȩȞĮ ǼȚțȩȞĮ

/ PRIME E PIERC

20mm

SAMP LE

ǹĳĮȚȡȑıĲİĲĮįİȓȖȝĮĲĮĲȠȣȚıĲȠȪĮʌȩĲȠȞȣʌȠįȠȤȑĮįİȚȖȝȐĲȦȞıĲȡȑĳȠȞĲĮȢĲȠțĮʌȐțȚ ĮȡȚıĲİȡȩıĲȡȠĳĮǼȐȞĮʌĮȚĲȠȪȞĲĮȚʌȡȩıșİĲĮįİȓȖȝĮĲĮȕİȕĮȚȦșİȓĲİȩĲȚʌȡȚȞĮʌȩĲȘȜȒȥȘ ĲȦȞʌȡȩıșİĲȦȞįİȚȖȝȐĲȦȞĲȠțĮʌȐțȚĲȠȣȣʌȠįȠȤȑĮįİȚȖȝȐĲȦȞȑȤİȚĲȠʌȠșİĲȘșİȓıĲȘșȑıȘĲȠȣ ȈǾȂǼǿȍȈǾȅȣʌȠįȠȤȑĮȢįİȚȖȝȐĲȦȞȝʌȠȡİȓȞĮĮĳĮȚȡİșİȓİȞĲİȜȫȢĮʌȩĲȠȞțĮșİĲȒȡĮ ĲȡĮȕȫȞĲĮȢʌȡȠȢĲĮʌȐȞȦĲȠțĮʌȐțȚțĮȚȝʌȠȡİȓȞĮĮĳĮȚȡİșİȓʌȡȚȞȒȝİĲȐĮʌȩĲȘȞ ĮĳĮȓȡİıȘĲȠȣțĮșİĲȒȡĮĮʌȩĲȠȞȠįȘȖȩǼȐȞȠțĮșİĲȒȡĮȢİȓȞĮȚĲȠʌȠșİĲȘȝȑȞȠȢıĲȠȞȠįȘȖȩ țĮȚȠȣʌȠįȠȤȑĮȢįİȚȖȝȐĲȦȞȑȤİȚĮĳĮȚȡİșİȓĮʌȩĲȠȞțĮșİĲȒȡĮȠȚİȞįİȚțĲȚțȑȢȜȣȤȞȓİȢ ³35,0(3,(5&(´ ȆȇȅǼȉȅǿȂǹȈǿǹǻǿǹȉȇǾȈǾ țĮȚ³6$03/(´ ǻǼǿīȂǹȉȅȁǾȌǿǹ șĮ ĮȞĮȕȠıȕȒȞȠȣȞȝİʌȠȡĲȠțĮȜȓĳȦȢȂİĲȐĮʌȩĲȘȞİʌĮȞİȚıĮȖȦȖȒĲȠȣȣʌȠįȠȤȑĮįİȚȖȝȐĲȦȞ ıĲȠȞțĮșİĲȒȡĮȠȚİȞįİȚțĲȚțȑȢȜȣȤȞȓİȢ³35,0(3,(5&(´ ȆȇȅǼȉȅǿȂǹȈǿǹǻǿǹȉȇǾȈǾ țĮȚ³6$03/(´ ǻǼǿīȂǹȉȅȁǾȌǿǹ șĮİȓȞĮȚıȣȞİȤȫȢĮȞĮȝȝȑȞİȢȝİʌȡȐıȚȞȠĳȦȢ ǹĳĮȚȡȑıĲİĲȠȞțĮșİĲȒȡĮĮʌȩĲȠȞȠįȘȖȩʌȚȑȗȠȞĲĮȢʌȡȠȢĲĮțȐĲȦĲȘȖȜȦĲĲȓįĮĮıĳȐȜȚıȘȢ ȦșȫȞĲĮȢʌȜȒȡȦȢĲȠĳȠȡȑĮʌȡȠȢĲĮİȝʌȡȩȢțĮȚĲȡĮȕȫȞĲĮȢİȣșİȓĮĲȠȞțĮșİĲȒȡĮĮʌȩĲȠȞ ȠįȘȖȩ ǼȚțȩȞĮ ǼȚțȩȞĮ īȜȦĲĲȓįĮĮıĳȐȜȚıȘȢ

ȈǾȂǼǿȍȈǾǹĳȩĲȠȣȑȞĮȢțĮșİĲȒȡĮȢĮĳĮȚȡİșİȓĮʌȩĲȠȞȠįȘȖȩȝİĲȐĮʌȩȝȚĮįȚĮįȚțĮıȓĮ įİȞİȓȞĮȚįȣȞĮĲȩȞȞĮİʌĮȞİȚıĮȤșİȓǼȐȞĮʌĮȚĲȠȪȞĲĮȚʌȡȩıșİĲĮįİȓȖȝĮĲĮȚıĲȠȪ İȚıȐȖİĲİȑȞĮȞȑȠțĮșİĲȒȡĮıĲȠȞȠįȘȖȩ ȈǾȂǼǿȍȈǾȂİĲȐĲȘȞĮĳĮȓȡİıȘĲȠȣțĮșİĲȒȡĮȠȠįȘȖȩȢșĮȟİțȚȞȒıİȚĲȘȝȘȤĮȞȚțȒ İʌĮȞĮĳȠȡȐȂȘȞİȚıĮȖȐȖİĲİȞȑȠțĮșİĲȒȡĮʌȡȚȞĮʌȩĲȘȞȠȜȠțȜȒȡȦıȘĮȣĲȒȢĲȘȢ İʌĮȞĮĳȠȡȐȢ īȚĮıȘȝĮȞĲȚțȑȢʌȜȘȡȠĳȠȡȓİȢıȤİĲȚțȐȝİĲȠȞțĮșĮȡȚıȝȩțĮȚĲȘĳȩȡĲȚıȘĲȠȣȠįȘȖȠȪ ĮȞĮĲȡȑȟĲİıĲȚȢȠįȘȖȓİȢȤȡȒıȘȢĲȠȣȠįȘȖȠȪȕȚȠȥȓĮȢFINESSE® Ultra. ȈǾȂǼǿȍȈǾȅțĮșİĲȒȡĮȢȘȠȝȠĮȟȠȞȚțȒțȐȞȠȣȜĮțĮȚȠȣʌȠįȠȤȑĮȢįİȚȖȝȐĲȦȞ ʌȡȠȠȡȓȗȠȞĲĮȚȖȚĮȝȓĮȝȩȞȠȤȡȒıȘȂİĲȐĮʌȩĲȘȤȡȒıȘĲĮʌȡȠȧȩȞĲĮĮȣĲȐİȞįȑȤİĲĮȚ ȞĮĮʌȠĲİȜȠȪȞįȣȞȘĲȚțȩȕȚȠȜȠȖȚțȩțȓȞįȣȞȠȅȤİȚȡȚıȝȩȢțĮȚȘĮʌȩȡȡȚȥȒĲȠȣʌȡȑʌİȚ ȞĮȖȓȞȠȞĲĮȚıȪȝĳȦȞĮȝİĲȘȞĮʌȠįİțĲȒȚĮĲȡȚțȒʌȡĮțĲȚțȒțĮȚĲȠȣȢȚıȤȪȠȞĲİȢĲȠʌȚțȠȪȢ ʌȠȜȚĲİȚĮțȠȪȢțĮȚȠȝȠıʌȠȞįȚĮțȠȪȢȞȩȝȠȣȢțĮȚțĮȞȠȞȚıȝȠȪȢ , ȉȡȩʌȠȢįȚȐșİıȘȢ ȅȚțĮșİĲȒȡİȢȕȚȠȥȓĮȢFINESSE® 8OWUDʌĮȡȑȤȠȞĲĮȚıĲİȓȡȠȚȖȚĮȤȡȒıȘıİȑȞĮȞȝȩȞȠĮıșİȞȒ - ǼȖȖȪȘıȘ Ǿ%DUG3HULSKHUDO9DVFXODUʌĮȡȑȤİȚİȖȖȪȘıȘʌȡȠȢĲȠȞĮȡȤȚțȩĮȖȠȡĮıĲȒĲȠȣʌȡȠȧȩȞĲȠȢ ĮȣĲȠȪȩĲȚĲȠʌȡȠȧȩȞĮȣĲȩİȓȞĮȚĮʌĮȜȜĮȖȝȑȞȠĮʌȩİȜĮĲĲȫȝĮĲĮȩıȠȞĮĳȠȡȐĲĮȣȜȚțȐțĮȚ ĲȘȞțĮĲĮıțİȣȒȖȚĮʌİȡȓȠįȠİȞȩȢȑĲȠȣȢĮʌȩĲȘȞȘȝİȡȠȝȘȞȓĮĲȘȢʌȡȫĲȘȢĮȖȠȡȐȢǾİȣșȪȞȘ ıĲĮʌȜĮȓıȚĮĮȣĲȒȢĲȘȢʌİȡȚȠȡȚıȝȑȞȘȢİȖȖȪȘıȘȢʌȡȠȧȩȞĲȠȢʌİȡȚȠȡȓȗİĲĮȚıĲȘȞİʌȚıțİȣȒ ȒĮȞĲȚțĮĲȐıĲĮıȘĲȠȣİȜĮĲĲȦȝĮĲȚțȠȪʌȡȠȧȩȞĲȠȢțĮĲȐĲȘȞĮʌȠțȜİȚıĲȚțȒțȡȓıȘĲȘȢ%DUG 3HULSKHUDO9DVFXODUȒıĲȘȞİʌȚıĲȡȠĳȒĲȘȢțĮșĮȡȒȢĲȚȝȒȢʌȠȣțĮĲĮȕȜȒșȘțİǾʌĮȡȠȪıĮ ʌİȡȚȠȡȚıȝȑȞȘİȖȖȪȘıȘįİȞțĮȜȪʌĲİȚʌİȡȚʌĲȫıİȚȢĳșȠȡȐȢȜȩȖȦĳȣıȚȠȜȠȖȚțȒȢȤȡȒıȘȢ ȒİȜĮĲĲȫȝĮĲĮʌȠȣȠĳİȓȜȠȞĲĮȚıİİıĳĮȜȝȑȞȘȤȡȒıȘĲȠȣʌȡȠȧȩȞĲȠȢĮȣĲȠȪ ȈȉȅȂǼȉȇȅȆȅȊǼȆǿȉȇǼȆǼȉǹǿǹȆȅȉǾȃǿȈȋȊȅȊȈǹȃȅȂȅĬǼȈǿǹǾȆǼȇǿȅȇǿȈȂǼȃǾ ǹȊȉǾǼīīȊǾȈǾȊȆȅȀǹĬǿȈȉǹȀǹĬǼǹȁȁǾǼīīȊǾȈǾǼǿȉǼȇǾȉǾǼǿȉǼǼȂȂǼȈǾ ȈȊȂȆǼȇǿȁǹȂǺǹȃȅȂǼȃǾȈǹȁȁǹȋȍȇǿȈȃǹȆǼȇǿȅȇǿǽǼȉǹǿȂȅȃȅȈǼǹȊȉǾȀǹǿ ȀǹĬǼǼȂȂǼȈǾȈǼīīȊǾȈǾȈǼȂȆȅȇǼȊȈǿȂȅȉǾȉǹȈǳȀǹȉǹȁȁǾȁȅȉǾȉǹȈīǿǹǼȃǹ ȈȊīȀǼȀȇǿȂǼȃȅȈȀȅȆȅ+%$5'3(5,3+(5$/9$6&8/$5ǻǼȃǼǿȃǹǿȊȆǼȊĬȊȃǾ ȈǼȀǹȂǿǹȆǼȇǿȆȉȍȈǾīǿǹȉȊȋȅȃǼȂȂǼȈǼȈȉȊȋǹǿǼȈǳȆǹȇǼȆȅȂǼȃǼȈǽǾȂǿǼȈ ȆȅȊȆȇȅȀȊȆȉȅȊȃǹȆȅȉȅȋǼǿȇǿȈȂȅǳȉǾȋȇǾȈǾȉȅȊȆȇȅȎȅȃȉȅȈǹȊȉȅȊǹȆȅ ȂǼȇȅȊȈȈǹȈ ȈİȠȡȚıȝȑȞİȢȤȫȡİȢįİȞİʌȚĲȡȑʌİĲĮȚȘİȟĮȓȡİıȘĲȦȞȑȝȝİıȦȞİȖȖȣȒıİȦȞțĮșȫȢțĮȚĲȦȞ ĲȣȤĮȓȦȞȒʌĮȡİʌȩȝİȞȦȞȗȘȝȚȫȞȆȚșĮȞȩȞȞĮȑȤİĲİʌİȡĮȚĲȑȡȦįȚțĮȚȫȝĮĲĮĮʌȠȗȘȝȓȦıȘȢ ıȪȝĳȦȞĮȝİĲȘȞȠȝȠșİıȓĮĲȘȢȤȫȡĮȢıĮȢ īȚĮİȞȘȝȑȡȦıȘĲȠȣȤȡȒıĲȘıĲȘȞĲİȜİȣĲĮȓĮıİȜȓįĮĮȣĲȠȪĲȠȣĳȣȜȜĮįȓȠȣĮȞĮȖȡȐĳİĲĮȚ ȘȘȝİȡȠȝȘȞȓĮȑțįȠıȘȢȒĮȞĮșİȫȡȘıȘȢțĮșȫȢțĮȚȑȞĮȢĮȡȚșȝȩȢĮȞĮșİȫȡȘıȘȢĲȦȞȠįȘȖȚȫȞ ĮȣĲȫȞȈİʌİȡȓʌĲȦıȘʌȠȣȑȤȠȣȞȝİıȠȜĮȕȒıİȚȝȒȞİȢȝİĲĮȟȪĲȘȢȘȝİȡȠȝȘȞȓĮȢĮȣĲȒȢțĮȚ ĲȘȢȤȡȒıȘȢĲȠȣʌȡȠȧȩȞĲȠȢȠȤȡȒıĲȘȢșĮʌȡȑʌİȚȞĮİʌȚțȠȚȞȦȞȒıİȚȝİĲȘȞ%DUG3HULSKHUDO 9DVFXODU,QFȖȚĮȞĮİȞȘȝİȡȦșİȓİȐȞȣʌȐȡȤȠȣȞįȚĮșȑıȚȝİȢʌȡȩıșİĲİȢʌȜȘȡȠĳȠȡȓİȢȖȚĮĲȠʌȡȠȧȩȞ ȈȣȞĮȡȝȠȜȠȖİȓĲĮȚıĲȘȞȆȠȜȦȞȓĮ 24

ɂɧɫɬɪɭɤɰɢɢɩɨɩɪɢɦɟɧɟɧɢɸ

ɇɟɨɛɯɨɞɢɦɵɟɞɨɩɨɥɧɢɬɟɥɶɧɵɟɫɜɟɞɟɧɢɹɫɦɜɢɧɫɬɪɭɤɰɢɹɯ ɩɨɩɪɢɦɟɧɟɧɢɸɛɢɨɩɫɢɣɧɨɝɨɞɪɚɣɜɟɪɚFINESSE® Ultra. Ɉɞɧɨɤɪɚɬɧɨɝɨɩɪɢɦɟɧɟɧɢɹ

$ Ɉɩɢɫɚɧɢɟɭɫɬɪɨɣɫɬɜɚ

ɋɢɫɬɟɦɚɞɥɹɛɢɨɩɫɢɢɦɨɥɨɱɧɨɣɠɟɥɟɡɵ)INESSE®8OWUDɜɤɥɸɱɚɸɳɚɹɜɫɟɛɹ ɞɪɚɣɜɟɪɢɡɨɧɞɩɨɡɜɨɥɹɟɬɩɨɥɭɱɚɬɶɢɢɡɜɥɟɤɚɬɶɧɟɫɤɨɥɶɤɨɨɛɪɚɡɰɨɜɡɚɨɞɧɨ ɜɜɟɞɟɧɢɟɡɨɧɞɚɉɪɢɭɫɥɨɜɢɢɫɨɜɦɟɫɬɧɨɝɨɩɪɢɦɟɧɟɧɢɹɤɨɦɩɨɧɟɧɬɵɫɢɫɬɟɦɵ ɨɛɟɫɩɟɱɢɜɚɸɬɛɟɡɨɩɚɫɧɭɸɛɢɨɩɫɢɸɨɛɪɚɡɰɨɜɬɤɚɧɢɫɰɟɥɶɸɞɢɚɝɧɨɫɬɢɤɢ Ⱦɪɚɣɜɟɪɩɪɟɞɫɬɚɜɥɹɟɬɫɨɛɨɣɚɜɬɨɧɨɦɧɨɟɩɟɪɟɧɨɫɧɨɟɷɥɟɤɬɪɨɦɟɯɚɧɢɱɟɫɤɨɟ ɭɫɬɪɨɣɫɬɜɨɦɧɨɝɨɤɪɚɬɧɨɝɨɢɫɩɨɥɶɡɨɜɚɧɢɹɞɥɹɜɚɤɭɭɦɧɨɣɛɢɨɩɫɢɢɤɨɬɨɪɨɟ ɪɚɛɨɬɚɟɬɨɬɥɢɬɢɟɜɨɢɨɧɧɨɣɚɤɤɭɦɭɥɹɬɨɪɧɨɣɛɚɬɚɪɟɢɢɩɨɫɬɚɜɥɹɟɬɫɹɜɤɨɦɩɥɟɤɬɟ ɫɞɨɩɨɥɧɢɬɟɥɶɧɵɦɨɛɨɪɭɞɨɜɚɧɢɟɦɞɥɹɩɢɬɚɧɢɹɨɬɫɟɬɢɩɟɪɟɦɟɧɧɨɝɨɬɨɤɚ ɢɮɭɬɥɹɪɨɦȻɢɨɩɫɢɣɧɵɣɡɨɧɞɫɨɫɬɨɢɬɢɡɩɨɥɨɣɜɧɟɲɧɟɣɪɟɠɭɳɟɣɤɚɧɸɥɢ ɜɧɭɬɪɟɧɧɟɣɢɝɥɵɫɡɚɛɨɪɧɨɣɤɚɦɟɪɨɣɫɜɵɟɦɤɨɣɢɜɫɬɪɨɟɧɧɨɣɤɨɚɤɫɢɚɥɶɧɨɣ ɤɚɧɸɥɢȼɧɟɲɧɹɹɤɚɧɸɥɹɢɜɫɬɪɨɟɧɧɚɹɤɨɚɤɫɢɚɥɶɧɚɹɤɚɧɸɥɹɢɦɟɸɬ ɡɚɨɫɬɪɟɧɧɵɟɪɟɠɭɳɢɟɤɪɨɦɤɢɢɜɧɭɬɪɟɧɧɸɸɢɝɥɭɫɡɚɨɫɬɪɟɧɧɵɦɤɨɧɱɢɤɨɦ ɬɪɨɚɤɚɪɚȾɪɚɣɜɟɪɪɚɛɨɬɚɟɬɨɬɞɜɢɝɚɬɟɥɟɣɩɨɫɬɨɹɧɧɨɝɨɬɨɤɚɫɨɡɞɚɜɚɹ ɜɚɤɭɭɦɢɨɞɧɨɜɪɟɦɟɧɧɨɨɬɜɨɞɹɜɧɟɲɧɸɸɤɚɧɸɥɸɫɰɟɥɶɸɨɬɤɪɵɬɢɹ ɡɚɛɨɪɧɨɣɤɚɦɟɪɵɞɥɹɡɚɛɨɪɚɬɤɚɧɢȼɧɟɲɧɹɹɤɚɧɸɥɹɜɵɫɜɨɛɨɠɞɚɟɬɫɹ ɢɞɜɢɠɟɬɫɹɜɩɟɪɟɞɩɨɜɟɪɯɡɚɛɨɪɧɨɣɤɚɦɟɪɵɫɪɟɡɚɹɩɪɢɷɬɨɦɬɤɚɧɶɈɛɪɚɡɟɰ ɬɤɚɧɢɱɟɪɟɡɡɚɛɨɪɧɭɸɤɚɦɟɪɭɩɟɪɟɦɟɳɚɟɬɫɹɜɤɨɧɬɟɣɧɟɪɞɥɹɨɛɪɚɡɰɨɜ Ɂɚɬɟɦɡɚɛɨɪɧɚɹɤɚɦɟɪɚɜɨɡɜɪɚɳɚɟɬɫɹɜɫɜɨɟɩɟɪɜɨɧɚɱɚɥɶɧɨɟɩɨɥɨɠɟɧɢɟ ɢɝɨɬɨɜɚɤɡɚɛɨɪɭɞɪɭɝɨɝɨɨɛɪɚɡɰɚɉɨɫɥɟɩɪɨɜɟɞɟɧɢɹɛɢɨɩɫɢɢɜɫɬɪɨɟɧɧɚɹ ɤɨɚɤɫɢɚɥɶɧɚɹɤɚɧɸɥɹɦɨɠɟɬɛɵɬɶɨɬɫɨɟɞɢɧɟɧɚɢɨɫɬɚɜɥɟɧɚɜɦɨɥɨɱɧɨɣɠɟɥɟɡɟ ɱɬɨɛɵɫɨɯɪɚɧɢɬɶɫɥɟɞɨɬɦɟɫɬɚɛɢɨɩɫɢɢɩɪɢɩɨɦɟɳɟɧɢɢɬɭɞɚɛɢɨɥɨɝɢɱɟɫɤɨɝɨ ɦɚɪɤɟɪɚ ɉɊɂɆȿɑȺɇɂȿȼɫɬɪɨɟɧɧɭɸɤɨɚɤɫɢɚɥɶɧɭɸɤɚɧɸɥɸɧɟɥɶɡɹɨɬɫɨɟɞɢɧɹɬɶ ɜɨɜɪɟɦɹɡɚɛɨɪɚɨɛɪɚɡɰɨɜɬɤɚɧɢ A B C D

ɇɨɦɟɪɩɨ ɤɚɬɚɥɨɝɭ

Ɉɩɢɫɚɧɢɟ

Ʉɚɥɢɛɪ

F14105US

ɍɥɶɬɪɚɡɜɭɤɨɜɨɣ ɛɢɨɩɫɢɣɧɵɣɡɨɧɞ

14G

ɦɦ

F10105US

ɍɥɶɬɪɚɡɜɭɤɨɜɨɣ ɛɢɨɩɫɢɣɧɵɣɡɨɧɞ

10G

ɦɦ

Ȼ ɉɨɤɚɡɚɧɢɹɞɥɹɩɪɢɦɟɧɟɧɢɹ

ɋɢɫɬɟɦɚɞɥɹɛɢɨɩɫɢɢɦɨɥɨɱɧɨɣɠɟɥɟɡɵFINESSE® 8OWUDɩɪɢɦɟɧɹɟɬɫɹɩɪɢɡɚɛɨɪɟ ɨɛɪɚɡɰɨɜɬɤɚɧɢɦɨɥɨɱɧɨɣɠɟɥɟɡɵɢɥɢɩɨɞɦɵɲɟɱɧɵɯɥɢɦɮɚɬɢɱɟɫɤɢɯɭɡɥɨɜ ɞɥɹɞɢɚɝɧɨɫɬɢɤɢɧɨɜɨɨɛɪɚɡɨɜɚɧɢɣɦɨɥɨɱɧɨɣɠɟɥɟɡɵɉɪɢɛɨɪɩɪɟɞɧɚɡɧɚɱɟɧ ɞɥɹɡɚɛɨɪɚɬɤɚɧɢɦɨɥɨɱɧɨɣɠɟɥɟɡɵɞɥɹɝɢɫɬɨɥɨɝɢɱɟɫɤɨɝɨɢɫɫɥɟɞɨɜɚɧɢɹ ɫɱɚɫɬɢɱɧɵɦɢɥɢɩɨɥɧɵɦɭɞɚɥɟɧɢɟɦɜɵɹɜɥɟɧɧɨɝɨɧɨɜɨɨɛɪɚɡɨɜɚɧɢɹ ȼɟɥɢɱɢɧɭɧɨɜɨɨɛɪɚɡɨɜɚɧɢɹɩɪɟɞɧɚɡɧɚɱɟɧɧɨɝɨɞɥɹɝɢɫɬɨɥɨɝɢɱɟɫɤɨɝɨ ɢɫɫɥɟɞɨɜɚɧɢɹɧɟɜɨɡɦɨɠɧɨɬɨɱɧɨɨɩɪɟɞɟɥɢɬɶɩɪɢɦɚɦɦɨɝɪɚɮɢɢɉɨɷɬɨɦɭ ɜɢɡɭɚɥɢɡɢɪɭɟɦɵɣɨɛɴɟɦɩɪɟɞɩɨɥɚɝɚɟɦɨɝɨɭɞɚɥɟɧɢɹɧɨɜɨɨɛɪɚɡɨɜɚɧɢɹ ɩɪɟɞɧɚɡɧɚɱɟɧɧɨɝɨɞɥɹɝɢɫɬɨɥɨɝɢɱɟɫɤɨɝɨɢɫɫɥɟɞɨɜɚɧɢɹɧɚɩɪɢɦɟɪ ɡɥɨɤɚɱɟɫɬɜɟɧɧɨɝɨɧɟɩɨɡɜɨɥɹɟɬɫɬɨɱɧɨɫɬɶɸɩɪɨɝɧɨɡɢɪɨɜɚɬɶɮɚɤɬɢɱɟɫɤɢɣ ɨɛɴɟɦɭɞɚɥɟɧɢɹȿɫɥɢɝɢɫɬɨɥɨɝɢɱɟɫɤɢɩɨɞɬɜɟɪɠɞɚɟɬɫɹɱɬɨɡɚɛɪɚɧɧɵɣɨɛɪɚɡɟɰ ɧɨɜɨɨɛɪɚɡɨɜɚɧɢɹɹɜɥɹɟɬɫɹɡɥɨɤɚɱɟɫɬɜɟɧɧɵɦɬɨɧɟɨɛɯɨɞɢɦɨɩɪɨɜɟɪɢɬɶɝɪɚɧɢɰɵ ɬɤɚɧɢɜɨɛɥɚɫɬɢɭɞɚɥɟɧɢɹɢɭɛɟɞɢɬɶɫɹɱɬɨɧɨɜɨɨɛɪɚɡɨɜɚɧɢɟɭɞɚɥɟɧɨɩɨɥɧɨɫɬɶɸ ɉɪɢɷɬɨɦɩɪɢɞɟɪɠɢɜɚɸɬɫɹɫɬɚɧɞɚɪɬɧɵɯɯɢɪɭɪɝɢɱɟɫɤɢɯɩɪɨɰɟɞɭɪ

ȼ ɉɪɨɬɢɜɨɩɨɤɚɡɚɧɢɹ

1. ɋɢɫɬɟɦɚɞɥɹɛɢɨɩɫɢɢɦɨɥɨɱɧɨɣɠɟɥɟɡɵFINESSE® 8OWUDɩɪɢɦɟɧɹɟɬɫɹ ɢɫɤɥɸɱɢɬɟɥɶɧɨɜɞɢɚɝɧɨɫɬɢɱɟɫɤɢɯɰɟɥɹɯɢɇȿɩɪɟɞɧɚɡɧɚɱɟɧɚɞɥɹɥɟɱɟɧɢɹ 2. ɋɢɫɬɟɦɚɞɥɹɛɢɨɩɫɢɢɦɨɥɨɱɧɨɣɠɟɥɟɡɵFINESSE® 8OWUDɩɪɨɬɢɜɨɩɨɤɚɡɚɧɚ ɞɥɹɩɪɢɦɟɧɟɧɢɹɭɩɚɰɢɟɧɬɨɜɜɫɥɭɱɚɹɯɟɫɥɢɫɨɝɥɚɫɧɨɜɪɚɱɟɛɧɨɦɭ ɦɧɟɧɢɸɩɪɢɫɭɬɫɬɜɭɟɬɩɨɜɵɲɟɧɧɵɣɪɢɫɤɨɫɥɨɠɧɟɧɢɣɫɜɹɡɚɧɧɵɯ ɫɱɪɟɫɤɨɠɧɵɦɢɦɟɬɨɞɚɦɢɡɚɛɨɪɚɨɛɪɚɡɰɨɜɬɤɚɧɢ

Ƚ ɉɪɟɞɭɩɪɟɠɞɟɧɢɹ

1. Ɋɢɫɤɨɫɥɨɠɧɟɧɢɣɦɨɠɟɬɛɵɬɶɜɵɲɟɭɩɚɰɢɟɧɬɨɜɫɧɚɪɭɲɟɧɢɹɦɢ ɫɜɟɪɬɵɜɚɟɦɨɫɬɢɤɪɨɜɢɢɥɢɩɪɨɯɨɞɹɳɢɯɥɟɱɟɧɢɟɚɧɬɢɤɨɚɝɭɥɹɧɬɚɦɢ Ʉɚɤɢɜɫɥɭɱɚɟɫɥɸɛɵɦɢɞɪɭɝɢɦɢɩɪɢɛɨɪɚɦɢɞɥɹɛɢɨɩɫɢɢ ɫɭɳɟɫɬɜɭɟɬɪɢɫɤɢɧɮɟɤɰɢɢ Ɂɚɩɪɟɳɚɟɬɫɹɩɨɜɬɨɪɧɨɟɢɫɩɨɥɶɡɨɜɚɧɢɟɛɢɨɩɫɢɣɧɵɯɡɨɧɞɨɜ FINESSE®8OWUDɉɨɜɬɨɪɧɨɟɢɫɩɨɥɶɡɨɜɚɧɢɟɡɨɧɞɚɫɨɩɪɹɠɟɧɨɫɪɢɫɤɨɦ ɩɟɪɟɤɪɟɫɬɧɨɝɨɡɚɪɚɠɟɧɢɹɩɚɰɢɟɧɬɨɜɩɨɫɤɨɥɶɤɭɛɢɨɩɫɢɣɧɵɟɡɨɧɞɵ² ɜɱɚɫɬɧɨɫɬɢɬɟɤɨɬɨɪɵɟɢɦɟɸɬɞɥɢɧɧɵɣɢɭɡɤɢɣɩɪɨɫɜɟɬɬɨɱɤɢ ɫɨɟɞɢɧɟɧɢɹɢɢɥɢɡɚɡɨɪɵɦɟɠɞɭɤɨɦɩɨɧɟɧɬɚɦɢ²ɬɪɭɞɧɨɢɥɢ ɧɟɜɨɡɦɨɠɧɨɨɱɢɫɬɢɬɶɩɨɫɥɟɤɨɧɬɚɤɬɚɛɢɨɥɨɝɢɱɟɫɤɢɯɠɢɞɤɨɫɬɟɣ ɢɥɢɬɤɚɧɟɣɩɨɬɟɧɰɢɚɥɶɧɨɫɨɞɟɪɠɚɳɢɯɩɢɪɨɝɟɧɧɵɟɜɟɳɟɫɬɜɚɢɥɢ ɦɢɤɪɨɨɪɝɚɧɢɡɦɵɫɛɢɨɩɫɢɣɧɵɦɡɨɧɞɨɦɜɬɟɱɟɧɢɟɧɟɨɩɪɟɞɟɥɟɧɧɨɝɨ ɩɟɪɢɨɞɚɜɪɟɦɟɧɢɈɫɬɚɬɤɢɛɢɨɥɨɝɢɱɟɫɤɨɝɨɦɚɬɟɪɢɚɥɚɦɨɝɭɬ ɫɩɨɫɨɛɫɬɜɨɜɚɬɶɡɚɝɪɹɡɧɟɧɢɸɡɨɧɞɚɩɢɪɨɝɟɧɧɵɦɢɜɟɳɟɫɬɜɚɦɢ ɢɥɢɦɢɤɪɨɨɪɝɚɧɢɡɦɚɦɢɤɨɬɨɪɵɟɦɨɝɭɬɩɪɢɜɟɫɬɢɤɢɧɮɟɤɰɢɨɧɧɵɦ ɨɫɥɨɠɧɟɧɢɹɦ Ɂɚɩɪɟɳɚɟɬɫɹɩɨɜɬɨɪɧɚɹɫɬɟɪɢɥɢɡɚɰɢɹɛɢɨɩɫɢɣɧɵɯɡɨɧɞɨɜ FINESSE®8OWUDɉɨɫɥɟɩɨɜɬɨɪɧɨɣɫɬɟɪɢɥɢɡɚɰɢɢɧɟɥɶɡɹɝɚɪɚɧɬɢɪɨɜɚɬɶ ɫɬɟɪɢɥɶɧɨɫɬɶɡɨɧɞɚɢɡɡɚɧɟɜɨɡɦɨɠɧɨɫɬɢɨɩɪɟɞɟɥɢɬɶɫɬɟɩɟɧɶ ɡɚɝɪɹɡɧɟɧɢɹɩɢɪɨɝɟɧɧɵɦɢɜɟɳɟɫɬɜɚɦɢɢɥɢɦɢɤɪɨɨɪɝɚɧɢɡɦɚɦɢ ɤɨɬɨɪɵɟɦɨɝɭɬɩɪɢɜɟɫɬɢɤɢɧɮɟɤɰɢɨɧɧɵɦɨɫɥɨɠɧɟɧɢɹɦɈɱɢɫɬɤɚ ɩɨɜɬɨɪɧɵɟɨɛɪɚɛɨɬɤɚɢɢɥɢɫɬɟɪɢɥɢɡɚɰɢɹɡɨɧɞɚɩɨɜɵɲɚɸɬ ɜɟɪɨɹɬɧɨɫɬɶɟɝɨɧɟɢɫɩɪɚɜɧɨɫɬɢɢɡɡɚɨɬɪɢɰɚɬɟɥɶɧɵɯɩɨɫɥɟɞɫɬɜɢɣ ɜɵɡɜɚɧɧɵɯɬɟɪɦɢɱɟɫɤɨɣɨɛɪɚɛɨɬɤɨɣɢɢɥɢɦɟɯɚɧɢɱɟɫɤɢɦɢ ɢɡɦɟɧɟɧɢɹɦɢɟɝɨɤɨɦɩɨɧɟɧɬɨɜ ȻɢɨɩɫɢɣɧɵɣɡɨɧɞFINESSE®8OWUDɪɚɡɪɟɲɚɟɬɫɹɢɫɩɨɥɶɡɨɜɚɬɶɬɨɥɶɤɨ ɫɛɢɨɩɫɢɣɧɵɦɞɪɚɣɜɟɪɨɦFINESSE® Ultra. ȼɫɟɨɩɟɪɚɰɢɢɩɨɛɢɨɩɫɢɢɦɨɥɨɱɧɨɣɠɟɥɟɡɵɫɥɟɞɭɟɬɩɪɨɜɨɞɢɬɶ ɩɨɞɜɢɡɭɚɥɢɡɚɰɢɨɧɧɵɦɤɨɧɬɪɨɥɟɦɗɬɨɩɨɦɨɝɚɟɬɨɬɫɥɟɠɢɜɚɬɶ ɩɨɥɨɠɟɧɢɟɡɨɧɞɚɨɬɧɨɫɢɬɟɥɶɧɨɡɨɧɵɢɧɬɟɪɟɫɚɜɤɨɬɨɪɨɣɧɟɨɛɯɨɞɢɦɨ ɩɪɨɢɡɜɟɫɬɢɡɚɛɨɪɢɫɧɢɠɚɟɬɜɟɪɨɹɬɧɨɫɬɶɥɨɠɧɨɨɬɪɢɰɚɬɟɥɶɧɨɣ ɛɢɨɩɫɢɢȻɢɨɩɫɢɣɧɵɣɡɨɧɞFINESSE®8OWUDɩɪɢɦɟɧɹɟɬɫɹɬɨɥɶɤɨ ɫɭɥɶɬɪɚɡɜɭɤɨɜɵɦɦɟɬɨɞɨɦɜɢɡɭɚɥɢɡɚɰɢɢ

ɊɍɋɋɄɂɃ

ɁɚɩɪɟɳɚɟɬɫɹɢɫɩɨɥɶɡɨɜɚɬɶɛɢɨɩɫɢɣɧɵɣɡɨɧɞFINESSE®8OWUDɛɟɡɜɫɬɪɨɟɧɧɨɣ ɤɨɚɤɫɢɚɥɶɧɨɣɤɚɧɸɥɢɉɨɫɥɟɩɪɨɜɟɞɟɧɢɹɛɢɨɩɫɢɢɜɫɬɪɨɟɧɧɚɹɤɨɚɤɫɢɚɥɶɧɚɹ ɤɚɧɸɥɹɦɨɠɟɬɛɵɬɶɨɬɫɨɟɞɢɧɟɧɚɱɬɨɛɵɫɨɯɪɚɧɢɬɶɫɥɟɞɨɬɦɟɫɬɚɛɢɨɩɫɢɢ ɩɪɢɩɨɦɟɳɟɧɢɢɬɭɞɚɛɢɨɥɨɝɢɱɟɫɤɨɝɨɦɚɪɤɟɪɚ ɄɷɤɫɩɥɭɚɬɚɰɢɢɫɢɫɬɟɦɵɞɥɹɛɢɨɩɫɢɢɦɨɥɨɱɧɨɣɠɟɥɟɡɵFINESSE® Ultra ɞɨɥɠɧɵɞɨɩɭɫɤɚɬɶɫɹɬɨɥɶɤɨɜɪɚɱɢɨɡɧɚɤɨɦɥɟɧɧɵɟɫɩɨɤɚɡɚɧɢɹɦɢ ɤɟɟɩɪɢɦɟɧɟɧɢɸɨɝɪɚɧɢɱɟɧɢɹɦɢɢɜɨɡɦɨɠɧɵɦɢɨɫɥɨɠɧɟɧɢɹɦɢɩɪɢ ɢɫɩɨɥɶɡɨɜɚɧɢɢɢɝɥɵɞɥɹɱɪɟɫɤɨɠɧɵɯɩɪɨɧɢɤɧɨɜɟɧɢɣ

ȿ ȼɨɡɦɨɠɧɵɟɨɫɥɨɠɧɟɧɢɹ

1. ȼɨɡɦɨɠɧɵɨɫɥɨɠɧɟɧɢɹɯɚɪɚɤɬɟɪɧɵɟɞɥɹɥɸɛɵɯɱɪɟɫɤɨɠɧɵɯɦɟɬɨɞɨɜ ɡɚɛɨɪɚɛɢɨɩɫɢɢɫɰɟɥɶɸɜɡɹɬɢɹɨɛɪɚɡɰɨɜɬɤɚɧɢȼɨɡɦɨɠɧɵɟɨɫɥɨɠɧɟɧɢɹ ɨɝɪɚɧɢɱɢɜɚɸɬɫɹɨɛɥɚɫɬɶɸɜɨɤɪɭɝɦɟɫɬɚɛɢɨɩɫɢɢɢɜɤɥɸɱɚɸɬɜɫɟɛɹ ɝɟɦɚɬɨɦɵɤɪɨɜɨɬɟɱɟɧɢɹɢɧɮɟɤɰɢɢɧɟɡɚɠɢɜɚɸɳɢɟɪɚɧɵɛɨɥɢɢɩɪɢɥɢɩɚɧɢɟ ɬɤɚɧɢɤɛɢɨɩɫɢɣɧɨɦɭɡɨɧɞɭɩɪɢɢɡɜɥɟɱɟɧɢɢɟɝɨɢɡɦɨɥɨɱɧɨɣɠɟɥɟɡɵ 2. ɋɨɝɥɚɫɧɨɫɬɚɧɞɚɪɬɧɨɣɩɪɚɤɬɢɤɟɩɪɢɩɪɨɜɟɞɟɧɢɢɛɢɨɩɫɢɢɜɨɡɦɨɠɧɨ ɩɨɬɪɟɛɭɟɬɫɹɪɚɡɪɟɡɚɬɶɬɤɚɧɶɧɚɥɢɩɲɭɸɧɚɛɢɨɩɫɢɣɧɵɣɡɨɧɞɩɪɢ ɢɡɜɥɟɱɟɧɢɢɟɝɨɢɡɦɨɥɨɱɧɨɣɠɟɥɟɡɵ

ɀɇɟɨɛɯɨɞɢɦɨɟɨɛɨɪɭɞɨɜɚɧɢɟ

Ⱦɥɹɩɪɨɜɟɞɟɧɢɹɛɢɨɩɫɢɢɧɟɨɛɯɨɞɢɦɨɫɥɟɞɭɸɳɟɟɨɛɨɪɭɞɨɜɚɧɢɟ ɋɨɨɬɜɟɬɫɬɜɭɸɳɟɟɨɛɨɪɭɞɨɜɚɧɢɟɜɢɡɭɚɥɢɡɚɰɢɢɢɞɨɩɨɥɧɢɬɟɥɶɧɨɟ ɨɛɨɪɭɞɨɜɚɧɢɟ ȻɂɈɉɋɂɃɇɕɃȾɊȺɃȼȿɊ),1(66(® Ultra ȻɂɈɉɋɂɃɇɕɃɁɈɇȾ),1(66(® Ultra ɏɢɪɭɪɝɢɱɟɫɤɢɟɩɟɪɱɚɬɤɢɢɫɚɥɮɟɬɤɢ Ɇɟɫɬɧɵɣɚɧɟɫɬɟɬɢɤ ɋɤɚɥɶɩɟɥɶ Ⱦɪɭɝɨɟɧɟɨɛɯɨɞɢɦɨɟɨɛɨɪɭɞɨɜɚɧɢɟ

Ɂɍɤɚɡɚɧɢɹɩɨɩɪɢɦɟɧɟɧɢɸ ɍɫɬɚɧɨɜɤɚɡɨɧɞɚɜɞɪɚɣɜɟɪ

ɍɛɟɞɢɬɟɫɶɱɬɨɞɪɚɣɜɟɪɩɨɥɧɨɫɬɶɸɡɚɪɹɠɟɧɉɨɫɥɟɞɧɟɜɧɨɝɨ ɢɫɩɨɥɶɡɨɜɚɧɢɹɞɪɚɣɜɟɪɧɟɨɛɯɨɞɢɦɨɨɫɬɚɜɢɬɶɧɚɧɨɱɶɧɚɡɚɪɹɞɤɭ ɉɪɢɦɟɧɹɹɚɫɟɩɬɢɱɟɫɤɭɸɦɟɬɨɞɢɤɭɢɡɜɥɟɤɢɬɟɡɨɧɞɢɡɭɩɚɤɨɜɤɢɡɚɯɜɚɬɢɜ ɟɝɨɫɧɢɡɭɍɛɟɞɢɬɟɫɶɜɬɨɦɱɬɨɡɨɧɞɨɫɬɚɥɫɹɫɬɟɪɢɥɶɧɵɦ ȼɫɬɚɜɶɬɟɡɨɧɞɜɞɪɚɣɜɟɪ ɪɢɫ ɂɡɜɥɟɤɢɬɟɮɢɤɫɢɪɭɸɳɢɣɲɬɢɮɬ ɪɢɫ ɋɞɜɢɧɶɬɟɩɟɪɟɦɟɳɚɸɳɟɟɭɫɬɪɨɣɫɬɜɨɡɨɧɞɚɧɚɡɚɞɭɛɟɞɢɜɲɢɫɶ ɱɬɨɫɬɨɩɨɪɧɚɞɟɠɧɨɡɚɮɢɤɫɢɪɨɜɚɥɫɹ ɪɢɫ Ɋɢɫ Ɋɢɫ Ɋɢɫ

ɉɊɂɆȿɑȺɇɂȿȾɪɚɣɜɟɪɧɟɢɦɟɟɬɜɵɤɥɸɱɚɬɟɥɹɩɢɬɚɧɢɹȾɪɚɣɜɟɪ ɚɜɬɨɦɚɬɢɱɟɫɤɢɨɩɪɟɞɟɥɹɟɬɬɢɩɡɨɧɞɚɮɚɤɬɩɪɚɜɢɥɶɧɨɣɭɫɬɚɧɨɜɤɢ ɡɨɧɞɚɢɜɵɩɨɥɧɹɟɬɢɧɢɰɢɚɥɢɡɚɰɢɸɫɰɟɥɶɸɫɢɧɯɪɨɧɢɡɚɰɢɢɞɪɚɣɜɟɪɚ ɢɡɨɧɞɚɉɪɢɩɪɚɜɢɥɶɧɨɣɭɫɬɚɧɨɜɤɟɡɨɧɞɚɞɪɚɣɜɟɪɩɨɞɚɟɬɬɪɢɡɜɭɤɨɜɵɯ ɫɢɝɧɚɥɚɢɢɧɞɢɤɚɬɨɪɵ35,0(3,(5&(ɢ6$03/(ɝɨɪɹɬɡɟɥɟɧɵɦȼɨɜɪɟɦɹ ɢɧɢɰɢɚɥɢɡɚɰɢɢɫɥɵɲɟɧɡɜɭɤɞɜɢɝɚɬɟɥɹ ɉɨɫɥɟɡɚɜɟɪɲɟɧɢɹɢɧɢɰɢɚɥɢɡɚɰɢɢɭɞɚɥɢɬɟɩɪɟɞɨɯɪɚɧɢɬɟɥɶɧɭɸɦɭɮɬɭ ɫɡɨɧɞɚ ɉɊɂɆȿɑȺɇɂȿɇɟɨɛɯɨɞɢɦɵɟɫɜɟɞɟɧɢɹɨɛɷɤɫɩɥɭɚɬɚɰɢɢɞɪɚɣɜɟɪɚɫɦ ɜɢɧɫɬɪɭɤɰɢɹɯɩɨɩɪɢɦɟɧɟɧɢɸɛɢɨɩɫɢɣɧɨɝɨɞɪɚɣɜɟɪɚFINESSE® Ultra.

ɉɪɨɜɟɞɟɧɢɟɛɢɨɩɫɢɢ

ɉɨɞɝɨɬɨɜɶɬɟɦɟɫɬɨɛɢɨɩɫɢɢɫɩɨɦɨɳɶɸɫɨɨɬɜɟɬɫɬɜɭɸɳɢɯɚɫɟɩɬɢɱɟɫɤɢɯ ɦɟɬɨɞɢɤɢɞɨɫɬɚɬɨɱɧɨɣɦɟɫɬɧɨɣɚɧɟɫɬɟɡɢɢɈɛɹɡɚɬɟɥɶɧɨɫɨɛɥɸɞɟɧɢɟ ɫɨɨɬɜɟɬɫɬɜɭɸɳɢɯɦɟɪɩɪɟɞɨɫɬɨɪɨɠɧɨɫɬɢɫɬɚɧɞɚɪɬɧɵɯɞɥɹɜɫɟɯɱɪɟɫɤɨɠɧɵɯ ɩɪɨɰɟɞɭɪ ɩɪɢɦɟɧɟɧɢɟɢɧɞɢɜɢɞɭɚɥɶɧɵɯɫɪɟɞɫɬɜɡɚɳɢɬɵɧɚɩɪɢɦɟɪ ɩɟɪɱɚɬɨɤɨɱɤɨɜɡɚɳɢɬɧɵɯɭɫɬɪɨɣɫɬɜɢɞɪ ɋɞɟɥɚɣɬɟɧɟɛɨɥɶɲɨɣɧɚɞɪɟɡɢɥɢɩɪɨɤɨɥɤɨɠɢɫɩɨɦɨɳɶɸɫɤɚɥɶɩɟɥɹ ɉɨɞɭɥɶɬɪɚɡɜɭɤɨɜɵɦɤɨɧɬɪɨɥɟɦɜɜɟɞɢɬɟɡɨɧɞɱɟɪɟɡɧɚɞɪɟɡɢɪɚɫɩɨɥɨɠɢɬɟ ɤɨɧɱɢɤɧɚɧɟɨɛɯɨɞɢɦɨɣɝɥɭɛɢɧɟ Ɋɢɫ ȿɫɥɢɬɪɟɛɭɟɬɫɹɩɪɨɤɚɥɵɜɚɬɶ ɩɨɪɚɠɟɧɧɵɣɭɱɚɫɬɨɤ ɪɚɫɩɨɥɨɠɢɬɟɤɨɧɱɢɤɡɨɧɞɚ ɭɝɪɚɧɢɰɵɩɨɪɚɠɟɧɧɨɝɨ Ʉɧɨɩɤɚ Ʉɧɨɩɤɚ ɭɱɚɫɬɤɚ Prime/Pierce Sample ȿɫɥɢɧɟɬɪɟɛɭɟɬɫɹ ɩɪɨɤɚɥɵɜɚɬɶɩɨɪɚɠɟɧɧɵɣ ɭɱɚɫɬɨɤɩɨɦɟɫɬɢɬɟ PRIME/ SAMPLE ɡɚɛɨɪɧɭɸɤɚɦɟɪɭɜɰɟɧɬɪ PIERCE ɡɨɧɵɢɧɬɟɪɟɫɚɐɟɧɬɪ ɡɚɛɨɪɧɨɣɤɚɦɟɪɵɧɚɯɨɞɢɬɫɹ ɩɪɢɛɥɢɡɢɬɟɥɶɧɨɜɦɦ ɨɬɤɨɧɱɢɤɚɡɨɧɞɚ ȿɫɥɢɬɪɟɛɭɟɬɫɹɜɵɩɨɥɧɢɬɶɩɪɨɤɨɥɞɨɜɜɟɞɟɧɢɹɡɨɧɞɚɜɦɨɥɨɱɧɭɸɠɟɥɟɡɭ ɧɚɠɦɢɬɟɤɧɨɩɤɭPRIME/PIERCEɱɬɨɛɵɨɬɜɟɫɬɢɡɨɧɞɧɚɦɦɉɨɫɥɟ ɜɜɟɞɟɧɢɹɡɨɧɞɚɧɚɠɦɢɬɟɤɧɨɩɤɭPRIME/PIERCEɱɬɨɛɵɩɪɨɞɜɢɧɭɬɶɡɨɧɞ ɧɚɦɦɜɡɨɧɭɢɧɬɟɪɟɫɚɩɟɪɟɞɬɟɦɤɚɤɜɵɩɨɥɧɢɬɶɡɚɛɨɪɩɟɪɜɨɝɨ ɨɛɪɚɡɰɚɬɤɚɧɢ ɪɢɫ ɉɊɂɆȿɑȺɇɂȿȾɥɹɨɬɫɥɟɠɢɜɚɧɢɹɩɨɥɨɠɟɧɢɹɡɨɧɞɚɨɬɧɨɫɢɬɟɥɶɧɨɡɨɧɵ ɢɧɬɟɪɟɫɚɜɤɨɬɨɪɨɣɧɟɨɛɯɨɞɢɦɨɩɪɨɢɡɜɟɫɬɢɡɚɛɨɪɨɛɪɚɡɰɚɫɥɟɞɭɟɬ ɩɪɢɦɟɧɹɬɶɦɟɬɨɞɵɜɢɡɭɚɥɢɡɚɰɢɨɧɧɨɝɨɤɨɧɬɪɨɥɹ ɉɊɂɆȿɑȺɇɂȿɉɪɢɩɟɪɜɨɧɚɱɚɥɶɧɨɦɪɚɡɦɟɳɟɧɢɢɡɨɧɞɚɪɟɤɨɦɟɧɞɭɟɬɫɹ ɩɪɨɞɜɢɝɚɬɶɡɨɧɞɜɬɤɚɧɶɜɪɟɠɢɦɟ35,0(3,(5&(ȼɨɜɪɟɦɹɩɨɫɥɟɞɭɸɳɢɯ ɡɚɛɨɪɨɜɨɛɪɚɡɰɨɜɜɪɚɱɦɨɠɟɬɢɝɧɨɪɢɪɨɜɚɬɶɷɬɨɞɟɣɫɬɜɢɟ ɉɊɂɆȿɑȺɇɂȿȼɫɥɭɱɚɟɟɫɥɢɬɪɟɛɭɸɬɫɹɞɨɩɨɥɧɢɬɟɥɶɧɵɟɩɪɨɤɨɥɵ ɧɚɩɪɢɦɟɪɞɥɹɞɨɫɬɭɩɚɤɛɨɥɟɟɩɥɨɬɧɵɦɬɤɚɧɹɦɢɥɢɩɨɪɚɠɟɧɧɵɦɭɱɚɫɬɤɚɦ ɦɨɠɧɨɜɡɜɨɞɢɬɶɡɨɧɞɤɨɝɞɚɨɧɭɠɟɧɚɯɨɞɢɬɫɹɜɧɭɬɪɢɬɟɥɚɩɚɰɢɟɧɬɚ 5. ɇɚɱɧɢɬɟɡɚɛɨɪɨɛɪɚɡɰɨɜɬɤɚɧɢɧɚɠɚɜɤɧɨɩɤɭSAMPLEɉɪɨɰɟɫɫɡɚɛɨɪɚ ɨɛɪɚɡɰɨɜɩɪɨɯɨɞɢɬɚɜɬɨɦɚɬɢɱɟɫɤɢɉɨɫɥɟɬɨɝɨɤɚɤɫɨɡɞɚɧɜɚɤɭɭɦ ɜɧɟɲɧɹɹɤɚɧɸɥɹɡɨɧɞɚɚɜɬɨɦɚɬɢɱɟɫɤɢɨɬɜɨɞɢɬɫɹɬɤɚɧɶɩɨɞɞɟɣɫɬɜɢɟɦ ɜɚɤɭɭɦɚɡɚɬɹɝɢɜɚɟɬɫɹɜɡɚɛɨɪɧɭɸɤɚɦɟɪɭɜɧɟɲɧɹɹɤɚɧɸɥɹɜɵɫɜɨɛɨɠɞɚɟɬɫɹ ɫɪɟɡɚɹɩɪɢɷɬɨɦɬɤɚɧɶɁɚɬɟɦɨɛɪɚɡɟɰɬɤɚɧɢɩɟɪɟɦɟɳɚɟɬɫɹɜɤɨɧɬɟɣɧɟɪɞɥɹ ɨɛɪɚɡɰɨɜȼɨɜɪɟɦɹɷɬɨɝɨɩɪɨɰɟɫɫɚɢɧɞɢɤɚɬɨɪSAMPLEɧɟɩɪɟɪɵɜɧɨɝɨɪɢɬ ɨɪɚɧɠɟɜɵɦɢɫɥɵɲɟɧɡɜɭɤɞɜɢɝɚɬɟɥɹɄɨɧɬɟɣɧɟɪɞɥɹɨɛɪɚɡɰɨɜ 20mm

ɊɍɋɋɄɂɃ

Ⱦ Ɇɟɪɵɩɪɟɞɨɫɬɨɪɨɠɧɨɫɬɢ

/ PRIME E PIERC

20mm

SAMP LE

8. ɂɡɜɥɟɤɢɬɟɨɛɪɚɡɰɵɬɤɚɧɢɢɡɤɨɧɬɟɣɧɟɪɚɞɥɹɨɛɪɚɡɰɨɜɩɨɜɟɪɧɭɜɤɪɵɲɤɭ ɩɪɨɬɢɜɱɚɫɨɜɨɣɫɬɪɟɥɤɢɉɪɢɧɟɨɛɯɨɞɢɦɨɫɬɢɩɨɥɭɱɟɧɢɹɞɨɩɨɥɧɢɬɟɥɶɧɵɯ ɨɛɪɚɡɰɨɜɭɫɬɚɧɨɜɢɬɟɤɪɵɲɤɭɤɨɧɬɟɣɧɟɪɚɞɥɹɨɛɪɚɡɰɨɜɧɚɦɟɫɬɨɩɟɪɟɞ ɬɟɦɤɚɤɧɚɱɚɬɶɡɚɛɨɪɞɪɭɝɢɯɨɛɪɚɡɰɨɜ ɉɊɂɆȿɑȺɇɂȿɄɨɧɬɟɣɧɟɪɞɥɹɨɛɪɚɡɰɨɜɦɨɠɧɨɢɡɜɥɟɱɶɢɡɡɨɧɞɚ ɰɟɥɢɤɨɦɩɨɞɧɹɜɡɚɤɪɵɲɤɭɩɟɪɟɞɬɟɦɢɥɢɩɨɫɥɟɬɨɝɨɤɚɤɡɨɧɞɛɭɞɟɬ ɢɡɜɥɟɱɟɧɢɡɞɪɚɣɜɟɪɚȼɫɥɭɱɚɟɟɫɥɢɡɨɧɞɭɫɬɚɧɨɜɥɟɧɜɞɪɚɣɜɟɪ ɛɟɡɤɨɧɬɟɣɧɟɪɚɞɥɹɨɛɪɚɡɰɨɜɢɧɞɢɤɚɬɨɪɵ35,0(3,(5&(ɢ6$03/( ɦɢɝɚɸɬɨɪɚɧɠɟɜɵɦɉɨɫɥɟɬɨɝɨɤɚɤɤɨɧɬɟɣɧɟɪɞɥɹɨɛɪɚɡɰɨɜɫɧɨɜɚ ɭɫɬɚɧɨɜɥɟɧɜɡɨɧɞɢɧɞɢɤɚɬɨɪɵ35,0(3,(5&(ɢ6$03/(ɧɟɩɪɟɪɵɜɧɨ ɝɨɪɹɬɡɟɥɟɧɵɦ 9. ɂɡɜɥɟɤɢɬɟɡɨɧɞɢɡɞɪɚɣɜɟɪɚɧɚɠɚɜɧɚɫɬɨɩɨɪɧɵɣɹɡɵɱɨɤɜɵɞɜɢɧɭɜ ɩɟɪɟɦɟɳɚɸɳɟɟɭɫɬɪɨɣɫɬɜɨɩɨɥɧɨɫɬɶɸɜɩɟɪɟɞɢɩɨɬɹɧɭɜɡɨɧɞ ɢɡɞɪɚɣɜɟɪɚ ɪɢɫ Ɋɢɫ ɋɬɨɩɨɪɧɵɣɹɡɵɱɨɤ

ɉɊɂɆȿɑȺɇɂȿɉɨɫɥɟɬɨɝɨɤɚɤɡɨɧɞɛɵɥɭɞɚɥɟɧɢɡɞɪɚɣɜɟɪɚɩɨɡɚɜɟɪɲɟɧɢɢ ɩɪɨɰɟɞɭɪɵɷɬɨɬɡɨɧɞɧɟɦɨɠɟɬɛɵɬɶɭɫɬɚɧɨɜɥɟɧɩɨɜɬɨɪɧɨȾɥɹɩɨɥɭɱɟɧɢɹ ɞɨɩɨɥɧɢɬɟɥɶɧɵɯɨɛɪɚɡɰɨɜɬɤɚɧɢɜɫɬɚɜɶɬɟɜɞɪɚɣɜɟɪɧɨɜɵɣɡɨɧɞ ɉɊɂɆȿɑȺɇɂȿɉɨɫɥɟɭɞɚɥɟɧɢɹɡɨɧɞɚɞɪɚɣɜɟɪɜɵɩɨɥɧɢɬɦɟɯɚɧɢɱɟɫɤɢɣ ɫɛɪɨɫɇɟɜɫɬɚɜɥɹɣɬɟɧɨɜɵɣɡɨɧɞɩɨɤɚɫɛɪɨɫɧɟɛɭɞɟɬɡɚɜɟɪɲɟɧ ɇɟɨɛɯɨɞɢɦɵɟɫɜɟɞɟɧɢɹɨɛɨɱɢɫɬɤɟɢɡɚɪɹɞɤɟɞɪɚɣɜɟɪɚɫɦɜɢɧɫɬɪɭɤɰɢɹɯ ɩɨɩɪɢɦɟɧɟɧɢɸɛɢɨɩɫɢɣɧɨɝɨɞɪɚɣɜɟɪɚFINESSE® Ultra. ɉɊɂɆȿɑȺɇɂȿɁɨɧɞɤɨɚɤɫɢɚɥɶɧɚɹɤɚɧɸɥɹɢɤɨɧɬɟɣɧɟɪɞɥɹɨɛɪɚɡɰɨɜ ɩɪɟɞɧɚɡɧɚɱɟɧɵɬɨɥɶɤɨɞɥɹɨɞɧɨɤɪɚɬɧɨɝɨɩɪɢɦɟɧɟɧɢɹɉɨɫɥɟ ɩɪɢɦɟɧɟɧɢɹɞɚɧɧɵɟɢɡɞɟɥɢɹɦɨɝɭɬɩɪɟɞɫɬɚɜɥɹɬɶɛɢɨɥɨɝɢɱɟɫɤɭɸ ɨɩɚɫɧɨɫɬɶɈɛɪɚɳɚɣɬɟɫɶɫɧɢɦɢɢɭɬɢɥɢɡɢɪɭɣɬɟɜɫɨɨɬɜɟɬɫɬɜɢɢ ɫɩɪɢɧɹɬɨɣɦɟɞɢɰɢɧɫɤɨɣɩɪɚɤɬɢɤɨɣɢɞɟɣɫɬɜɭɸɳɢɦɢɦɟɫɬɧɵɦɢ ɪɟɝɢɨɧɚɥɶɧɵɦɢɢɮɟɞɟɪɚɥɶɧɵɦɢɡɚɤɨɧɚɦɢɢɩɨɥɨɠɟɧɢɹɦɢ

ɂ Ʉɨɦɩɥɟɤɬɩɨɫɬɚɜɤɢ

ȻɢɨɩɫɢɣɧɵɣɡɨɧɞFINESSE®8OWUDɩɨɫɬɚɜɥɹɟɬɫɹɫɬɟɪɢɥɶɧɵɦɢɪɚɫɫɱɢɬɚɧ ɧɚɩɪɢɦɟɧɟɧɢɟɬɨɥɶɤɨɭɨɞɧɨɝɨɩɚɰɢɟɧɬɚ

Ʉ Ƚɚɪɚɧɬɢɹ Ʉɨɦɩɚɧɢɹ%DUG3HULSKHUDO9DVFXODUɜɬɟɱɟɧɢɟɨɞɧɨɝɨɝɨɞɚɫɨɞɧɹ ɩɟɪɜɨɧɚɱɚɥɶɧɨɣɩɨɤɭɩɤɢɝɚɪɚɧɬɢɪɭɟɬɩɟɪɜɨɧɚɱɚɥɶɧɨɦɭɩɨɤɭɩɚɬɟɥɸ ɞɚɧɧɨɝɨɢɡɞɟɥɢɹɨɬɫɭɬɫɬɜɢɟɜɞɚɧɧɨɦɢɡɞɟɥɢɢɞɟɮɟɤɬɨɜɦɚɬɟɪɢɚɥɨɜ ɢɩɪɨɢɡɜɨɞɫɬɜɟɧɧɨɝɨɛɪɚɤɚɈɬɜɟɬɫɬɜɟɧɧɨɫɬɶɩɨɞɚɧɧɨɣɨɝɪɚɧɢɱɟɧɧɨɣ ɝɚɪɚɧɬɢɢɧɚɢɡɞɟɥɢɟɨɝɪɚɧɢɱɢɜɚɟɬɫɹɪɟɦɨɧɬɨɦɢɥɢɡɚɦɟɧɨɣɧɟɢɫɩɪɚɜɧɨɝɨ ɢɡɞɟɥɢɹɢɥɢɜɨɡɦɟɳɟɧɢɟɦɟɝɨɩɨɥɧɨɣɫɬɨɢɦɨɫɬɢɩɨɭɫɦɨɬɪɟɧɢɸɤɨɦɩɚɧɢɢ %DUG3HULSKHUDO9DVFXODUȾɚɧɧɚɹɨɝɪɚɧɢɱɟɧɧɚɹɝɚɪɚɧɬɢɹɧɟɩɨɤɪɵɜɚɟɬ ɧɨɪɦɚɥɶɧɵɣɢɡɧɨɫɚɬɚɤɠɟɧɟɢɫɩɪɚɜɧɨɫɬɢɩɪɨɢɫɬɟɤɚɸɳɢɟɢɡɢɫɩɨɥɶɡɨɜɚɧɢɹ ɢɡɞɟɥɢɹɧɟɩɨɧɚɡɧɚɱɟɧɢɸ ȼɈȻɔȿɆȿɉɊȿȾɍɋɆɈɌɊȿɇɇɈɆȾȿɃɋɌȼɍɘɓɂɆ ɁȺɄɈɇɈȾȺɌȿɅɖɋɌȼɈɆȾȺɇɇȺəɈȽɊȺɇɂɑȿɇɇȺəȽȺɊȺɇɌɂəɇȺ ɂɁȾȿɅɂȿɂɋɄɅɘɑȺȿɌȼɋȿɈɋɌȺɅɖɇɕȿȽȺɊȺɇɌɂɂəȼɇɕȿɂɅɂ ɉɈȾɊȺɁɍɆȿȼȺȿɆɕȿȼɑȺɋɌɇɈɋɌɂɅɘȻɕȿɉɈȾɊȺɁɍɆȿȼȺȿɆɕȿ ȽȺɊȺɇɌɂɂɄɈɆɆȿɊɑȿɋɄɈɃɉɊɂȽɈȾɇɈɋɌɂɂɅɂɋɈɈɌȼȿɌɋɌȼɂə ɈɉɊȿȾȿɅȿɇɇɈɃɐȿɅɂɇɂɉɊɂɄȺɄɂɏɍɋɅɈȼɂəɏɄɈɆɉȺɇɂə%$5' 3(5,3+(5$/9$6&8/$5ɇȿɇȿɋȿɌɈɌȼȿɌɋɌȼȿɇɇɈɋɌɖɁȺɅɘȻɕȿ ɉɊəɆɕȿɋɅɍɑȺɃɇɕȿɂɅɂɄɈɋȼȿɇɇɕȿɍȻɕɌɄɂɉɊɈɂɋɌȿɄȺɘɓɂȿ ɂɁɈȻɊȺɓȿɇɂəɋȾȺɇɇɕɆɂɁȾȿɅɂȿɆɂɅɂȿȽɈɂɋɉɈɅɖɁɈȼȺɇɂə ȼɧɟɤɨɬɨɪɵɯɪɟɝɢɨɧɚɯɫɬɪɚɧɚɯɧɟɞɟɣɫɬɜɭɟɬɢɫɤɥɸɱɟɧɢɟɩɨɞɪɚɡɭɦɟɜɚɟɦɵɯ ɝɚɪɚɧɬɢɣɫɥɭɱɚɣɧɵɯɢɥɢɤɨɫɜɟɧɧɵɯɭɛɵɬɤɨɜɋɨɝɥɚɫɧɨɡɚɤɨɧɚɦɬɚɤɢɯ ɪɟɝɢɨɧɨɜɫɬɪɚɧɩɨɥɶɡɨɜɚɬɟɥɸɦɨɝɭɬɛɵɬɶɩɪɟɞɨɫɬɚɜɥɟɧɵɞɨɩɨɥɧɢɬɟɥɶɧɵɟ ɫɪɟɞɫɬɜɚɩɪɚɜɨɜɨɣɡɚɳɢɬɵ Ⱦɥɹɭɜɟɞɨɦɥɟɧɢɹɩɨɥɶɡɨɜɚɬɟɥɹɧɚɩɨɫɥɟɞɧɟɣɫɬɪɚɧɢɰɟɛɪɨɲɸɪɵɭɤɚɡɚɧɵ ɞɚɬɚɜɵɩɭɫɤɚɢɥɢɪɟɞɚɤɰɢɢɢɧɨɦɟɪɪɟɞɚɤɰɢɢɞɚɧɧɵɯɢɧɫɬɪɭɤɰɢɣȿɫɥɢ ɫɭɤɚɡɚɧɧɨɣɞɚɬɵɞɨɩɪɢɦɟɧɟɧɢɹɢɡɞɟɥɢɹɩɪɨɲɥɨɦɟɫɹɰɟɜɬɨɧɟɨɛɯɨɞɢɦɨ ɨɛɪɚɬɢɬɶɫɹɜɤɨɦɩɚɧɢɸ%DUG3HULSKHUDO9DVFXODU,QFɞɥɹɩɪɨɜɟɪɤɢɧɚɥɢɱɢɹ ɞɨɩɨɥɧɢɬɟɥɶɧɨɣɢɧɮɨɪɦɚɰɢɢɨɛɢɡɞɟɥɢɢ ɋɨɛɪɚɧɨɜɉɨɥɶɲɟ 57

ɊɍɋɋɄɂɃ

ɩɨɞɫɜɟɱɢɜɚɟɬɫɹɱɬɨɛɵɨɛɪɚɡɟɰɬɤɚɧɢɛɵɥɜɢɞɟɧɉɨɫɥɟɬɨɝɨɤɚɤɨɛɪɚɡɟɰ ɬɤɚɧɢɩɨɦɟɳɟɧɜɤɨɧɬɟɣɧɟɪɞɥɹɨɛɪɚɡɰɨɜɫɢɫɬɟɦɚɜɨɡɜɪɚɳɚɟɬɫɹ ɜɢɫɯɨɞɧɨɟɩɨɥɨɠɟɧɢɟɱɬɨɩɨɡɜɨɥɹɟɬɜɡɹɬɶɞɪɭɝɨɣɨɛɪɚɡɟɰ ɉɊɂɆȿɑȺɇɂȿȼɨɜɪɟɦɹɩɨɥɭɱɟɧɢɹɨɛɪɚɡɰɨɜɬɤɚɧɢɧɟɥɶɡɹɧɚɠɢɦɚɬɶɧɚ ɤɨɧɬɟɣɧɟɪɞɥɹɨɛɪɚɡɰɨɜɢɥɢɨɬɫɨɟɞɢɧɹɬɶɟɝɨ ɑɬɨɛɵɩɨɥɭɱɢɬɶɧɟɫɤɨɥɶɤɨɨɛɪɚɡɰɨɜɩɨɜɬɨɪɢɬɟɨɩɢɫɚɧɧɵɣɜɵɲɟɷɬɚɩ ɉɊɂɆȿɑȺɇɂȿɋɛɨɪɧɟɫɤɨɥɶɤɢɯɨɛɪɚɡɰɨɜɦɨɠɟɬɫɧɢɡɢɬɶɜɟɪɨɹɬɧɨɫɬɶ ɥɨɠɧɨɨɬɪɢɰɚɬɟɥɶɧɨɣɛɢɨɩɫɢɢ ɉɨɫɥɟɩɨɥɭɱɟɧɢɹɩɨɫɥɟɞɧɟɝɨɨɛɪɚɡɰɚɬɤɚɧɢɭɞɚɥɢɬɟɡɨɧɞɢɡɦɨɥɨɱɧɨɣ ɠɟɥɟɡɵɢɨɛɪɚɛɨɬɚɣɬɟɧɚɞɥɟɠɚɳɢɦɨɛɪɚɡɨɦɦɟɫɬɨɧɚɞɪɟɡɚ ɉɊɂɆȿɑȺɇɂȿɉɟɪɟɞɬɟɦɤɚɤɭɞɚɥɢɬɶɡɨɧɞɢɡɦɨɥɨɱɧɨɣɠɟɥɟɡɵ ɜɫɬɪɨɟɧɧɭɸɤɨɚɤɫɢɚɥɶɧɭɸɤɚɧɸɥɸɦɨɠɧɨɨɬɫɨɟɞɢɧɢɬɶɢɨɫɬɚɜɢɬɶ ɜɦɨɥɨɱɧɨɣɠɟɥɟɡɟɱɬɨɛɵɫɨɯɪɚɧɢɬɶɫɥɟɞɨɬɦɟɫɬɚɛɢɨɩɫɢɢɩɪɢ ɩɨɦɟɳɟɧɢɢɬɭɞɚɛɢɨɥɨɝɢɱɟɫɤɨɝɨɦɚɪɤɟɪɚ ɪɢɫ Ɋɢɫ

Ultrasound Biopsy Probe 6RQGHjELRSVLHpFKRJXLGpH Ultraschall-Biopsiesonde 6RQGDELRSWLFDSHUHFRJUD¿D Sonda de biopsia ecodirigida Ultrasone biopsiesonde Sonda para Biopsia Guiada por Ultra-sons ȀĮșİĲȒȡĮȢȕȚȠȥȓĮȢȝİȣʌİȡȒȤȠȣȢ Biopsisonde til ultralyd Biopsinål för ultraljudsledd biopsi Ultraääniohjattu biopsiakoetin Ultralyd biopsisonde 3UyEQLNGRELRSVMLSU]XĪFLXXOWUDVRQRJUD¿L 8OWUDKDQJRVELRSV]LiVV]RQGD 8OWUD]YXNRYiELRSWLFNiVRQGD Ultrason Biyopsi Probu 超声活检探针 초음파 생검용 프로브 ɍɥɶɬɪɚɡɜɭɤɨɜɨɣɛɢɨɩɫɢɣɧɵɣɡɨɧɞ

Attention, See Instructions For Use Attention, lire le mode d’emploi Achtung, Gebrauchsanweisung einsehen Attenzione! Vedere le istruzioni per l’uso Atención: Consultar las instrucciones de uso Attentie, zie gebruiksaanwijzing $WHQomR&RQVXOWHDV,QVWUXo}HVGH8WLOL]DomR ȆȡȠıȠȤȒĮȞĮĲȡȑȟĲİıĲȚȢȠįȘȖȓİȢȤȡȒıȘȢ 2EV/ VEUXJVDQYLVQLQJHQ Obs! Se bruksanvisningen +XRPLR/XHNlWW|RKMHHW OBS, Se bruksanvisningen 8ZDJDQDOHĪ]DSR]QDüVLĊ],QVWUXNFMąREVáXJL )LJHOHP/iVGD+DV]QiODWLXWDVtWiVW 3R]RUYL]1iYRGNSRXåLWt 'LNNDW.XOODQPD7DOLPDWÕQD%DNÕQÕ] 注意，请见《使用说明》 주의, 설명서 참조 ȼɧɢɦɚɧɢɟɋɦɢɧɫɬɪɭɤɰɢɢɩɨɩɪɢɦɟɧɟɧɢɸ

Contents Contenu Inhalt Contenuto Contenido Inhoud Conteúdo ȆİȡȚİȤȩȝİȞȠ Indhold Innehåll Sisältö Innhold =DZDUWRĞü Tartalom Obsah øoLQGHNLOHU 内装物品 내용 ɋɨɞɟɪɠɢɦɨɟ

Catalogue Number Numéro de catalogue Katalognummer Numero di catalogo Número de referencia Catalogusnummer 1~PHURGH&DWiORJR ǹȡȚșȝȩȢțĮĲĮȜȩȖȠȣ Katalognummer Katalognummer /XHWWHORQXPHUR Katalognummer Numer katalogowy .DWDOyJXVV]iP .DWDORJRYpþtVOR .DWDORJ1XPDUDVÕ 目录编号 카탈로그 번호 ɇɨɦɟɪɩɨɤɚɬɚɥɨɝɭ

Lot Number Numéro de lot Chargennummer Numero di lotto Número de lote /RWQXPPHU 1~PHURGR/RWH ǹȡȚșȝȩȢʌĮȡĲȓįĮȢ /RWQXPPHU /RWQXPPHU Eränumero Partinummer Numer partii 6RUR]DWV]iP ýtVORãDUåH /RW1XPDUDVÕ 批号 /RW번호 ɇɨɦɟɪɩɚɪɬɢɢ

Manufacturer: Bard Peripheral Vascular, Inc. 1625 West 3rd Street Tempe, AZ 85281 USA 7(/ 1-800-321-4254 FAX: 1-480-966-7062 1-800-440-5376 www.bardbiopsy.com Authorised Representative in the European Community %DUG/LPLWHG Crawley RH11 9BP, UK

27406-3021048 6/11

Previous Page Next Page

BARD

BARD Biopsy System

Finesse Ultra Probe Instructions for Use Rev 6 June 2011